No definition available.
Dental caries 2 and operation codes, only avohilmo
K11_CARIES_2_OPER_ONLYAVO
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
278821 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
46711 |
6. Filter based on genotype QC (FinnGen only) |
46711 |
Control definitions (FinnGen only)
- Control conditions
- K11_DENTAL_OPER
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Dental caries 2 and operation codes, only avohilmo
based on the number of shared cases.
Similar with more cases:
- Dental caries 2 and operation codes
- Dental caries 2, only avohilmo
- Dental caries 2
- Dental caries 1 and operation codes, only avohilmo
- Dental caries 1 and operation codes
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 417740 | 234443 | 181938 |
| Only index persons | 382635 | 217799 | 164836 |
| Unadjusted period prevalence (%) | |||
| Whole population | 5.99 | 6.72 | 5.08 |
| Only index persons | 7.27 | 8.01 | 6.29 |
| Median age at first event (years) | |||
| Whole population | 21.49 | 24.87 | 17.04 |
| Only index persons | 23.23 | 27.21 | 17.96 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 46711 | 32444 | 14267 |
| Unadjusted period prevalence (%) | 9.60 | 11.06 | 6.29 |
| Median age at first event (years) | 45.08 | 42.23 | 51.54 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 21202
- Matched controls
- 158530
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K03.64
ICD-10 Finland
Dental calculus supragingival
2.9
323.0
11361
44644
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.8
323.0
8558
43117
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
2.7
323.0
5048
16526
D82
ICPC
Teeth/gum disease
1.9
323.0
11070
58854
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
2.6
323.0
16824
94749
K03.66
ICD-10 Finland
Tooth plaque
4.5
323.0
3396
6513
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.9
323.0
12617
70063
SAA02
NOMESCO Finland
Basic examination of mouth
6.3
323.0
20916
145846
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
2.1
323.0
7244
31933
K02.0
ICD-10 Finland
Caries limited to enamel
+∞
323.0
21203
600
K02.1
ICD-10 Finland
Caries of dentine
1.9
291.5
17132
109455
K03.00
ICD-10 Finland
Approximal wear
2.9
284.9
2035
5654
K05.1
ICD-10 Finland
Chronic gingivitis
2.4
258.3
2570
8616
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.6
243.0
13787
84004
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.6
218.7
7881
42085
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.7
216.0
17275
113495
K03.0
ICD-10 Finland
Excessive attrition of teeth
3.2
206.4
1244
3054
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.6
174.0
7737
42828
SDA02
NOMESCO Finland
Parodonthologic therapy
1.5
168.0
10072
59519
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.6
166.5
15896
104118
D19
ICPC
Teeth/gum symptom/complaint
1.5
163.8
7678
42849
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
161.9
18965
130609
K02.3
ICD-10 Finland
Arrested dental caries
4.2
144.6
610
1109
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.5
121.9
7167
41224
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.5
120.2
7089
40768
K05.18
ICD-10 Finland
Chronic gingivitis
2.1
116.5
1561
5886
VALMI
NOMESCO Finland
NA
1.4
114.7
7273
42317
EB1SA
SPAT
NA
2.3
114.0
1139
3757
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.7
110.0
2870
13579
K05.30
ICD-10 Finland
Periodontitis complex
1.5
106.3
3906
20173
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.7
95.3
2265
10396
Z01.2
ICD-10 Finland
Dental examination
1.3
90.3
11958
77690
WZA90
NOMESCO Finland
Other doctors statement
1.4
85.9
6438
38069
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
85.1
15385
104453
WKPAL
NOMESCO Finland
NA
2.7
84.6
650
1853
K03.1
ICD-10 Finland
Abrasion of teeth
2.3
84.2
869
2903
K03.11
ICD-10 Finland
Abrasion dentifrice of teeth
2.4
82.9
802
2596
SFA00
NOMESCO Finland
Small filling
1.5
75.5
3620
19622
K05.19
ICD-10 Finland
Gingivitis (chronic) ulcerative
2.5
73.6
651
2008
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
73.5
7419
45692
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
70.6
12785
85324
WX290
NOMESCO Finland
Other blockade of nerve
1.3
70.2
11413
75013
K06.00
ICD-10 Finland
Local gingivore traction
2.9
69.2
460
1200
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
66.4
11922
79119
K06.0
ICD-10 Finland
Gingival recession
3.7
54.5
262
538
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.8
54.5
1026
4353
K07.61
ICD-10 Finland
Cracking jaw joint
2.5
50.8
432
1308
EBA15
NOMESCO Finland
Extraction of large number of teeth
0.4
50.3
273
4627
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
49.6
7877
50707
K03.18
ICD-10 Finland
Other abrasion of the teeth
2.5
48.6
424
1302
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
46.8
7869
50887
WX110
NOMESCO Finland
Local anesthesy
1.3
45.9
16809
118633
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.5
44.5
1834
9552
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
1.4
42.6
2696
15212
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.3
39.0
2748
15759
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
38.3
11158
75847
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
37.9
2099
11557
K03.09
ICD-10 Finland
Abrasion of the teeth UNS
2.6
37.7
300
877
-2
ICD-10 Finland
NA
2.1
37.7
445
1582
K03.2
ICD-10 Finland
Erosion of teeth
2.1
37.2
466
1700
F45.8
ICD-10 Finland
Other somatoform disorders
1.5
37.1
1355
6864
K06.01
ICD-10 Finland
General gingival retraction
3.2
37.0
210
494
A98
ICPC
Health maint/preventive medicine
1.6
36.3
20515
150362
K03.19
ICD-10 Finland
Abrasion of the teeth UNS
2.7
36.0
268
754
K03.80
ICD-10 Finland
Irradiated enamel
1.6
35.8
1044
5015
ZYC01
SPAT
NA
0.5
35.8
282
4220
SDE04
NOMESCO Finland
Periodontal treatment by dental hygienist, very extensive
1.3
34.6
2651
15379
R01AD09
ATC
mometasone; nasal
1.2
33.5
8355
55651
ZXH06
SPAT
NA
0.3
32.3
77
1831
K08.80
ICD-10 Finland
Toothache NOS
1.4
31.7
1725
9452
Z51.5
ICD-10 Finland
Palliative care
0.5
31.4
280
4037
SGA01
NOMESCO Finland
Tooth opening as first aid
1.3
31.3
3742
23016
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.3
31.1
2431
14124
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.2
30.8
6777
44495
J02AC01
ATC
fluconazole; systemic
1.2
30.8
7021
46255
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
2.3
30.4
298
973
J01FA10
ATC
azithromycin; systemic
1.2
30.0
10609
72650
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.3
28.3
2307
13477
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
27.5
8781
71995
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.3
27.4
2153
12503
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.2
27.4
5509
35761
R06AE07
ATC
cetirizine; oral
1.2
27.2
7831
52511
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
27.0
2033
11733
SPAT1312
SPAT
General health counselling
1.2
26.7
5481
35631
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.5
25.7
1072
5579
M03BX02
ATC
tizanidine; oral
1.2
25.3
12411
86726
205
Kela drug reimbursment
Chronic hypertension
0.8
24.8
3045
27222
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.3
24.8
1994
11612
A28
ICPC
Limited function/disability NOS
0.7
24.5
1293
12802
ZXH09
SPAT
NA
0.3
24.1
56
1342
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.3
23.9
2285
13624
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.2
23.9
3544
22258
K10.00
ICD-10 Finland
Torus mandibularis
2.5
23.8
195
581
TPH07
NOMESCO Finland
Cathetrisation of artery
0.7
23.8
926
9608
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
23.7
638
3005
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
0.7
23.6
563
6379
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.4
23.6
1124
6006
SGC10
NOMESCO Finland
Covering pulpa of tooth
1.3
23.4
1938
11325
C03CA01
ATC
furosemide; systemic
0.8
23.2
2824
25286
OAB42
SPAT
NA
0.5
23.0
252
3426
I50.9
ICD-10 Finland
Heart failure, unspecified
0.7
22.8
795
8402
SPAT1192
SPAT
Gynaecological examination
1.5
22.6
831
4216
SPAT1283
SPAT
Restricted health certificate
1.3
22.3
2646
16193
SPAT1097
SPAT
Recording of ECG
0.8
22.1
1769
16601
SPAT1310
SPAT
Counselling related to known health issue
1.2
22.1
5663
37420
EB1AA
SPAT
NA
1.4
21.9
1006
5335
WX720
NOMESCO Finland
Own respiration
0.6
21.5
273
3566
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.4
21.0
1359
7653
SAB02
NOMESCO Finland
Oral and dental health check by dental hygienist or dental assistant
1.5
21.0
885
4616
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.2
20.9
5604
37138
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
1.3
20.1
1391
7913
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.8
19.9
2640
23476
N95.1
ICD-10 Finland
Menopausal and female climacteric states
1.3
19.8
1634
9538
M01AH05
ATC
etoricoxib; oral
1.1
19.8
11725
82288
WZA00
NOMESCO Finland
Short statement of of health and health related matters
1.3
19.7
1296
7317
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
19.7
1955
17910
C07AB07
ATC
bisoprolol; oral
0.9
19.7
6650
54780
K02.2
ICD-10 Finland
Caries of cementum
1.4
19.6
1018
5528
K03.60
ICD-10 Finland
Deposits [accretions] on teeth black
2.4
19.5
174
546
FP1B5
NOMESCO Finland
Resting ECG, 12 leads
0.2
19.4
23
783
SCF01
NOMESCO Finland
Preventive oral care by dental hygienist or dental assistant, restricted
1.5
19.4
642
3184
C08CA01
ATC
amlodipine; oral
0.9
19.4
4757
40130
WX704
NOMESCO Finland
Intubation
0.7
19.3
690
7263
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
0.7
19.3
818
8374
130
Kela drug reimbursment
Malignant tumour
0.7
19.2
572
6215
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
1.3
19.1
1260
7114
N02AA05
ATC
oxycodone; systemic
0.8
18.9
1468
13839
M25.5
ICD-10 Finland
Pain in joint
1.2
18.9
5289
35114
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
0.8
18.8
1590
14833
K03.28
ICD-10 Finland
Other erosion of teeth
1.8
18.7
315
1294
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.2
18.6
3302
21059
K05.0
ICD-10 Finland
Acute gingivitis
1.7
18.5
433
1967
SXC05
NOMESCO Finland
Other oral or dental procedure
1.4
18.5
1151
6441
R06AX22
ATC
ebastine; oral
1.2
18.3
2797
17576
R06AX27
ATC
desloratadine; oral
1.2
18.2
4415
28949
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
18.1
5620
37586
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.3
18.1
1506
8797
H25.1
ICD-10 Finland
Senile nuclear cataract
0.8
18.0
2298
20534
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
0.8
17.9
1457
13664
K03.29
ICD-10 Finland
Erosion of teeth occupational
1.9
17.8
253
976
SCF03
NOMESCO Finland
Preventive oral care by dental hygienist, extensive
1.9
17.7
266
1050
HSOP
NOMESCO Finland
NA
3.2
17.1
92
213
WZC30
NOMESCO Finland
Teaching
0.8
17.0
1535
14220
-31
ICPC
Medical examin/health eval partial
0.7
16.8
595
6272
R01AD12
ATC
fluticasone furoate; nasal
1.2
16.8
5011
33376
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
1.4
16.7
882
4801
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.2
16.7
3687
23960
AN1
HP
Coronary angiography
0.8
16.6
1027
9962
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.2
16.5
3732
24305
OAB43
SPAT
NA
1.2
16.5
2431
15206
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
16.4
3046
19490
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.7
16.3
796
7980
R01AD08
ATC
fluticasone; nasal
1.2
16.2
4870
32443
WX725
NOMESCO Finland
Noninvasive ventilation
0.7
16.2
377
4286
C10AA01
ATC
simvastatin; oral
0.9
15.6
5986
49109
K86
ICPC
Hypertension uncomplicated
0.8
15.6
1216
11462
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
1.4
15.5
763
4102
SPAT1316
SPAT
Extensive health check-up of children and adolescents
1.8
15.4
253
1031
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
0.7
15.4
438
4799
SPAT1308
SPAT
Sexual health counselling
1.5
15.4
632
3283
J18.9
ICD-10 Finland
Pneumonia, unspecified
0.8
15.2
2441
21384
WX110
SPAT
NA
1.4
15.2
911
5068
SAB03
NOMESCO Finland
Oral health check
1.6
15.2
381
1765
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.2
15.2
3758
24633
C01DA14
ATC
isosorbide mononitrate; oral
0.8
15.1
1143
10811
K13.1
ICD-10 Finland
Cheek and lip biting
2.5
15.0
122
368
J01CA04
ATC
amoxicillin; systemic
1.1
14.7
15569
112259
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
1.5
14.7
476
2353
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.7
14.6
698
7023
I48
ICD-10 Finland
Atrial fibrillation and flutter
0.8
14.5
2115
18688
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
0.4
14.4
66
1183
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
0.7
14.4
516
5423
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.2
14.3
1923
11903
G03AC03
ATC
levonorgestrel; systemic
1.2
14.3
1921
11895
A06AC01
ATC
ispaghula (psylla seeds); oral
1.2
14.2
4070
26967
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.3
14.2
1308
7745
A10BA02
ATC
metformin; oral
0.9
14.2
3393
28789
G02BA03
ATC
plastic IUD with progestogen
1.3
14.1
1544
9343
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
1.3
13.9
1209
7102
SPC01
NOMESCO Finland
Fixed dental crown
1.7
13.9
269
1158
K03.81
ICD-10 Finland
Sensitive dentine
3.0
13.9
81
200
SGB30
NOMESCO Finland
Other demanding filling of root channel of tooth
1.2
13.9
2529
16131
G01AF05
ATC
econazole; vaginal
1.3
13.9
1248
7366
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
13.9
18210
132929
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
1.9
13.8
194
751
K05.08
ICD-10 Finland
Another acute gingivitis
1.5
13.7
416
2027
G01AA10
ATC
clindamycin; vaginal
1.2
13.6
2199
13868
WX290
SPAT
NA
1.5
13.6
480
2419
M01AE02
ATC
naproxen; oral, rectal
1.1
13.6
10225
72043
S02.50
ICD-10 Finland
Fracture of tooth, closed
1.6
13.5
377
1803
WF049
NOMESCO Finland
Radiotherapy of metastasis
0.6
13.3
178
2287
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.1
13.3
7355
50885
A49.9
ICD-10 Finland
Bacterial infection, unspecified
0.8
13.2
961
9139
103
Kela drug reimbursment
Diabetes, insulin-treated
0.9
13.2
3323
28111
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
1.2
13.2
3013
19603
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
0.6
13.0
179
2287
K05.3
ICD-10 Finland
Chronic periodontitis
1.3
13.0
1201
7114
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
0.8
13.0
1902
16812
B01AA03
ATC
warfarin; systemic
0.8
13.0
1878
16613
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.6
12.8
173
2215
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.8
12.8
2491
21490
B01AC04
ATC
clopidogrel; oral
0.8
12.7
1515
13653
XX3DW
NOMESCO Finland
Time consuming IT work
0.8
12.5
1107
10289
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.2
12.4
2380
15255
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.9
12.3
3069
25997
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
0.8
12.3
1650
14700
K03.61
ICD-10 Finland
Coatings in tobacco smokers
3.3
12.1
61
137
WW200
SPAT
NA
0.8
12.1
1025
9568
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
0.4
12.0
58
1014
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.1
12.0
4717
31910
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
1.4
12.0
569
3047
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.2
11.9
2475
15961
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.1
11.9
5914
40593
N06AX12
ATC
bupropion; oral
1.3
11.9
884
5089
MAX99
NOMESCO Finland
Assistance to normal delivery
1.7
11.8
258
1156
WX702
NOMESCO Finland
Supraglottic ventilation device
0.7
11.8
497
5090
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
0.2
11.8
15
486
J02AC02
ATC
itraconazole; systemic
1.2
11.7
2952
19349
-
ICD-10 Finland
NA
1.6
11.7
338
1631
SPA30
NOMESCO Finland
Grinding of a single crown and bridge pillar or a single post and crown
1.8
11.6
218
933
TAKUU
NOMESCO Finland
NA
1.8
11.6
207
872
C10AA05
ATC
atorvastatin; oral
0.9
11.6
5453
44385
E0000UV
ATC
NA
1.1
11.6
6548
45259
G03DB01
ATC
dydrogesterone; oral
1.2
11.5
1841
11592
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
0.6
11.5
182
2243
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.4
11.5
649
3581
N06DX01
ATC
memantine; oral
0.6
11.4
231
2698
N06DA02
ATC
donepezil; oral
0.6
11.4
207
2471
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
2.0
11.3
144
540
J01AA04
ATC
lymecycline; systemic
1.2
11.3
1777
11175
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.2
11.2
1248
7568
Z39.2
ICD-10 Finland
Routine postpartum follow-up
1.6
11.1
310
1486
Z10.0
ICD-10 Finland
Occupational health examination
1.3
11.0
835
4819
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.2
11.0
2377
15376
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.9
10.9
3312
27701
K76
ICPC
Ischaemic heart dis without angina
0.6
10.8
128
1695
K04.08
ICD-10 Finland
Other specified pulpit
1.2
10.7
1222
7426
Z46.9
ICD-10 Finland
Fitting and adjustment of unspecified device
0.3
10.7
18
501
D10AX03
ATC
azelaic acid; topical
1.3
10.7
727
4132
EBA30
NOMESCO Finland
Excision of root of tooth
0.8
10.7
716
6872
G01AF01
ATC
metronidazole; vaginal
1.2
10.7
1572
9821
G04CA02
ATC
tamsulosin; oral
0.9
10.7
2357
20158
M79.1
ICD-10 Finland
Myalgia
1.2
10.6
2099
13475
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.2
10.6
1754
11083
A04AA02
ATC
granisetron; systemic, transdermal
0.7
10.6
523
5231
D10BA01
ATC
isotretinoin; oral
1.3
10.6
672
3781
R03AC02
ATC
salbutamol; inhalant
1.1
10.6
9373
66255
Z30.5
ICD-10 Finland
Surveillance of (intrauterine) contraceptive device
1.4
10.5
575
3157
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
3.6
10.5
48
100
SGA04
NOMESCO Finland
Very demanding opening and dilatation of root canal of tooth
1.2
10.5
2379
15452
TPH04
NOMESCO Finland
Cathetrisation of vein
0.9
10.5
2695
22799
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.2
10.5
1640
10308
M03BC51
ATC
orphenadrine, combinations; systemic
1.1
10.4
4940
33759
J20
ICD-10 Finland
Acute bronchitis
1.2
10.4
1413
8755
M54.5
ICD-10 Finland
Low back pain
1.1
10.4
5990
41395
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
1.5
10.4
378
1923
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.9
10.3
2560
21712
Z23.6
ICD-10 Finland
Need for immunization against diphtheria alone
3.4
10.3
51
114
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.3
10.3
676
3826
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.5
10.2
60
980
S02.51
ICD-10 Finland
Fracture of tooth, open
1.2
10.2
2336
15177
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.1
10.2
6797
47324
H02AB02
ATC
dexamethasone; systemic
0.8
10.2
1011
9280
T90
ICPC
Diabetes non-insulin dependent
0.9
10.2
3094
25890
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.3
10.1
806
4686
W12
ICPC
Contraception intrauterine
1.4
10.1
575
3181
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.5
10.1
58
953
AN2
HP
Balloon angioplasty, including several vessels
0.6
10.1
165
2017
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
1.4
10.1
545
2987
SAA03
NOMESCO Finland
Extended examination of mouth
1.1
10.0
10982
78354
PARO
NOMESCO Finland
NA
2.3
10.0
97
323
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
1.6
10.0
248
1153
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
1.5
10.0
337
1687
M79.6
ICD-10 Finland
Pain in limb
1.1
10.0
6487
45092
J35.0
ICD-10 Finland
Chronic tonsillitis
1.4
10.0
552
3039
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
1.3
10.0
762
4404
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
0.7
10.0
396
4088
Z37.0
ICD-10 Finland
Single live birth
1.4
10.0
466
2491
R06AE09
ATC
levocetirizine; oral
1.2
9.9
2150
13911
OAB47
SPAT
NA
0.5
9.9
88
1260
G47.8
ICD-10 Finland
Other sleep disorders
2.1
9.8
115
418
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
0.7
9.8
262
2892
L82
ICD-10 Finland
Seborrhoeic keratosis
1.2
9.8
2434
15920
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
1.4
9.8
426
2248
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.3
9.7
829
4865
KAY20
NOMESCO Finland
NA
2.2
9.7
102
352
R01AD01
ATC
beclometasone; nasal
1.2
9.7
2453
16066
SPAT1059
SPAT
Spirometry at the office
0.7
9.7
490
4883
Z30.2
ICD-10 Finland
Sterilization
1.2
9.7
1763
11237
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.2
9.7
2150
13939
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
1.6
9.7
276
1332
SPAT1195
SPAT
Antenatal classes
2.0
9.6
126
477
OAA65
SPAT
NA
1.2
9.6
1297
8032
Z87
ICD-10 Finland
Personal history of other diseases and conditions
1.8
9.6
161
669
SPAT1240
SPAT
Therapeutic discussion
1.2
9.5
1550
9776
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
1.6
9.5
223
1025
SPE90
NOMESCO Finland
Other fitting and preparation of partial tooth prosthesis
0.7
9.5
247
2739
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.7
9.4
463
4627
K0401
ICD-10 Finland
NA
1.7
9.3
184
804
C09AA05
ATC
ramipril; oral
0.9
9.3
2971
24790
G03HB01
ATC
cyproterone and estrogen; systemic
1.3
9.3
942
5655
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
0.7
9.3
312
3307
-42
ICPC
Electrical tracing
0.5
9.3
75
1101
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
1.6
9.1
245
1164
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
0.8
9.1
626
5992
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
0.7
9.1
214
2421
C09AA02
ATC
enalapril; systemic
0.9
9.1
2236
18992
K07.60
ICD-10 Finland
Snapping jaw
1.3
9.0
828
4908
SFC92
NOMESCO Finland
Other demanding adjuvant procedure of filling therapy
1.2
9.0
1452
9156
SPAT1104
SPAT
Monitoring of emergency patient
0.8
8.9
656
6220
M01AG02
ATC
tolfenamic acid; oral, rectal
1.2
8.9
2310
15159
WX892
NOMESCO Finland
Monitored bed care
0.8
8.8
673
6357
K03.10
ICD-10 Finland
Abrasion of the teeth caused toothpaste
2.8
8.8
55
145
K78
ICPC
Atrial fibrillation/flutter
0.8
8.7
614
5858
H10
ICD-10 Finland
Conjunctivitis
1.3
8.7
777
4591
K87
ICPC
Hypertension complicated
0.6
8.7
115
1474
K10.3
ICD-10 Finland
Alveolitis of jaws
1.3
8.7
773
4566
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
0.8
8.7
551
5323
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
0.4
8.6
28
568
F21
ICPC
NA
0.3
8.6
13
382
SPAT1336
SPAT
Request for examination
1.4
8.5
496
2756
R07.0
ICD-10 Finland
Pain in throat
1.3
8.5
810
4825
I50.0
ICD-10 Finland
Congestive heart failure
0.7
8.5
345
3543
E000001
ATC
NA
1.1
8.5
3076
20651
J01FA01
ATC
erythromycin; systemic
1.2
8.5
1972
12831
KAY40
NOMESCO Finland
NA
1.8
8.4
144
603
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.1
8.4
8980
63786
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
0.5
8.4
73
1049
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.2
8.4
1270
7964
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.3
8.3
694
4066
UGC12
NOMESCO Finland
Flexible bronchoscopy
0.8
8.3
682
6388
K04.00
ICD-10 Finland
Hyperemia of pulp
1.3
8.3
764
4532
OAB48
SPAT
NA
1.2
8.2
1083
6692
K03.88
ICD-10 Finland
Other specified diseases of hard tissues of teeth
1.4
8.2
414
2246
UJF30
NOMESCO Finland
Ileoscopy through colon
1.2
8.2
1438
9136
H02AB04
ATC
methylprednisolone; systemic
1.2
8.2
2210
14541
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
0.9
8.1
1527
13233
N05CF02
ATC
zolpidem; oral
1.1
8.1
2881
19314
SGA05
NOMESCO Finland
Very demanding and lengthy opening and dilatation of root canal of tooth
1.2
8.1
1207
7554
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.2
8.1
1147
7146
L43
ICD-10 Finland
Lichen planus
1.7
8.0
155
677
D10AF01
ATC
clindamycin; topical
1.3
8.0
623
3616
SPD05
NOMESCO Finland
Demanding fitting of total teeth prosthesis
0.2
8.0
11
340
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.7
7.9
319
3280
M04AA01
ATC
allopurinol; systemic
0.8
7.9
1212
10676
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
0.8
7.9
652
6103
SPAT1360
SPAT
Extensive global examination
1.2
7.9
1070
6632
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
1.4
7.9
446
2472
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.4
7.9
434
2395
K03.08
ICD-10 Finland
Other wear and tear of the teeth
1.4
7.8
420
2306
SPAT1254
SPAT
Administration of medicine
0.9
7.8
1622
13947
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
0.7
7.8
404
4007
SPAT1153
SPAT
Removal of sutures
1.1
7.8
5790
40414
M77.1
ICD-10 Finland
Lateral epicondylitis
1.2
7.8
1181
7404
ZXD10
NOMESCO Finland
Scheduled procedure
1.1
7.8
6346
44486
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
1.5
7.8
251
1252
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.9
7.8
1434
12438
N06AB10
ATC
escitalopram; oral
1.1
7.7
3089
20853
K11.70
ICD-10 Finland
Hypoptyalism
1.8
7.7
121
493
RD211
NOMESCO Finland
NA
0.8
7.7
431
4229
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
1.4
7.7
328
1728
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
0.6
7.7
102
1308
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
1.6
7.7
172
783
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.2
7.7
1363
8668
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
0.5
7.7
67
960
M01AC06
ATC
meloxicam; systemic, rectal
1.1
7.7
6605
46407
C01AA05
ATC
digoxin; systemic
0.7
7.7
398
3944
G30.8
ICD-10 Finland
Other Alzheimer disease
0.4
7.7
39
664
-50
ICPC
Medication/prescr/renewal
0.7
7.7
367
3680
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
1.3
7.6
501
2841
E03
ICD-10 Finland
Other hypothyroidism
1.3
7.6
748
4478
C07AB02
ATC
metoprolol; systemic
0.9
7.6
2223
18666
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
1.7
7.6
142
615
NG2AA
NOMESCO Finland
Patella X-ray examination
1.4
7.6
392
2139
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.8
7.6
1217
10678
SPAT1236
SPAT
Informing family of child’s disability
0.6
7.6
88
1165
K00.09
ICD-10 Finland
Lack of teeth due to lack of dental development UNS
1.5
7.6
266
1349
SPD01
NOMESCO Finland
Mucosa-supported complete denture
0.5
7.6
48
760
LOHK
NOMESCO Finland
NA
2.1
7.6
82
290
HARJA
NOMESCO Finland
NA
2.3
7.5
68
223
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
1.2
7.5
1650
10684
I20.99
ICD-10 Finland
Angina pectoris, unspecified
0.8
7.5
473
4568
B01AB10
ATC
tinzaparin; parenteral
0.8
7.5
656
6100
Z23.5
ICD-10 Finland
Need for immunization against tetanus alone
1.9
7.5
111
445
G44.2
ICD-10 Finland
Tension-type headache
1.2
7.5
2018
13277
I35.0
ICD-10 Finland
Aortic (valve) stenosis
0.8
7.5
394
3895
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.2
7.4
985
6093
A02BC04
ATC
rabeprazole; oral
1.2
7.4
1271
8057
K13.78
ICD-10 Finland
Other change in the oral mucosa
1.4
7.4
379
2064
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
0.6
7.4
126
1520
SCE00
NOMESCO Finland
Fissure closure of tooth
1.8
7.4
126
529
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
1.4
7.4
303
1588
LGA21
NOMESCO Finland
Laparoscopic sterilisation by constriction of Fallopian tubes
1.2
7.4
801
4849
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.3
7.4
686
4078
SHARJ
NOMESCO Finland
NA
5.3
7.4
22
31
I86.0
ICD-10 Finland
Sublingual varices
6.0
7.4
20
25
J31.0
ICD-10 Finland
Chronic rhinitis
1.2
7.3
1162
7322
M54
ICD-10 Finland
Dorsalgia
1.2
7.3
1663
10807
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.2
7.3
1738
11331
SPAT1212
SPAT
Extensive examination of musculoskeletal system
1.2
7.2
1230
7797
C61
ICD-10 Finland
Malignant neoplasm of prostate
0.8
7.2
689
6343
M03BC01
ATC
orphenadrine (citrate); systemic
1.1
7.2
4058
27923
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
1.3
7.2
560
3255
R03BB04
ATC
tiotropium bromide; inhalant
0.8
7.2
889
7981
R21
ICPC
Throat symptom/complaint
1.1
7.2
2812
18959
N76.0
ICD-10 Finland
Acute vaginitis
1.3
7.1
489
2792
J01DA01
ATC
[U] cefalexin; systemic
1.1
7.1
11458
82548
R05
ICD-10 Finland
Cough
1.1
7.1
3074
20843
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
0.8
7.1
646
5981
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
0.8
7.1
679
6250
Z25.1
ICD-10 Finland
Need for immunization against influenza
1.3
7.1
655
3895
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
0.7
7.0
195
2131
SPB05
NOMESCO Finland
Temporary prefabricated or laboratory-made dental or implant crown or bridge unit
3.0
7.0
40
100
Z02.4
ICD-10 Finland
Examination for driving licence
0.9
7.0
3006
24690
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
1.7
7.0
142
631
Z30.0
ICD-10 Finland
General counselling and advice on contraception
1.4
7.0
344
1867
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
1.4
7.0
352
1917
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
0.7
7.0
355
3524
JDB10
NOMESCO Finland
Percutaneous gastrostomy
0.5
7.0
63
889
M70.6
ICD-10 Finland
Trochanteric bursitis
1.1
6.9
1943
12815
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.4
6.9
371
2043
R74
ICPC
Upper respiratory infection acute
1.1
6.9
4500
31184
A48
ICPC
General and Unspecified, Clarification/discussion RFE/demand
1.2
6.9
716
4317
FP1C5
NOMESCO Finland
Resting ECG, 15 leads
0.4
6.9
21
437
AN4
HP
Balloon angioplasty and drug eluding stent
0.7
6.9
221
2353
E66.8
ICD-10 Finland
Other obesity
1.2
6.9
758
4603
Z2221
NOMESCO Finland
Medical doctor
1.1
6.9
4202
29031
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.1
6.9
1899
12518
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
0.5
6.8
67
926
Z3232
NOMESCO Finland
Midwife
1.4
6.8
370
2041
J01AA02
ATC
doxycycline; systemic
1.1
6.8
15033
109600
A29
ICPC
General symptom/complaint other
0.9
6.8
1250
10845
XQ845
NOMESCO Finland
Dermatoscopy
0.5
6.8
55
803
WX872
NOMESCO Finland
Intensive care
0.8
6.8
448
4299
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.2
6.7
1715
11236
M01AB05
ATC
diclofenac; systemic, rectal
1.1
6.7
12806
92775
F32
ICD-10 Finland
Depressive episode
1.3
6.7
660
3955
R01BA51
ATC
phenylpropanolamine, combinations; oral
1.2
6.7
1470
9520
WF004
NOMESCO Finland
Palliative radiotherapy
0.6
6.7
84
1088
-60
ICPC
Result test/procedure
0.8
6.7
566
5277
207
Kela drug reimbursment
Chronic arrhythmias
0.9
6.7
1385
11911
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
1.4
6.7
282
1488
J01FA09
ATC
clarithromycin; systemic
1.1
6.7
5251
36696
SAA04
NOMESCO Finland
Special inverstigation of mouth
0.8
6.7
847
7582
N40
ICD-10 Finland
Hyperplasia of prostate
0.9
6.6
2090
17477
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
0.5
6.6
57
817
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
0.7
6.6
214
2278
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.3
6.6
599
3555
C03DA01
ATC
spironolactone; oral
0.8
6.6
942
8346
SPB06
NOMESCO Finland
Production of temporary clinic-made tooth- or implant-retained crown or bridge unit
1.8
6.6
104
429
G01AF04
ATC
miconazole; vaginal
1.2
6.6
714
4327
WVA30
SPAT
NA
0.7
6.6
196
2113
H92.0
ICD-10 Finland
Otalgia
1.3
6.5
665
3999
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.2
6.5
1107
7018
K00.3
ICD-10 Finland
Mottled teeth
59.9
6.5
8
*
G01AF02
ATC
clotrimazole; vaginal
1.3
6.5
536
3142
D01BA02
ATC
terbinafine; oral; topical
1.1
6.5
4130
28574
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
1.7
6.5
137
617
O32.1
ICD-10 Finland
Maternal care for breech presentation
1.4
6.5
271
1429
J01DA08
ATC
[U] cefaclor; oral
1.2
6.5
1262
8096
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
0.2
6.5
5
217
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
0.6
6.5
104
1268
K05.32
ICD-10 Finland
Periodontitis NOS
1.3
6.5
561
3311
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
0.9
6.4
1983
16597
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
0.8
6.4
561
5208
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
1.3
6.4
526
3083
R44
ICPC
Respiratory, Preventive immunization/medic
0.6
6.3
71
947
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.9
6.3
2568
21154
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.8
6.3
482
4542
ZX070
NOMESCO Finland
Intensity modified radiotherapy
0.6
6.3
121
1418
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
1.4
6.3
258
1356
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.3
6.3
555
3287
-1
NOMESCO Finland
NA
1.1
6.2
7920
56426
SFB40
NOMESCO Finland
Filling of four surfaces reproduced outside mouth
1.7
6.2
124
549
D06BX01
ATC
metronidazole; topical
1.2
6.2
1480
9650
R06AX13
ATC
loratadine; oral
1.1
6.2
2158
14438
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.3
6.2
559
3316
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
1.4
6.2
285
1528
K03.22
ICD-10 Finland
Erosion of teeth due to: diet
1.6
6.2
142
655
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
0.9
6.2
3903
31457
R2110
NOMESCO Finland
Giving the first information
1.2
6.2
893
5582
Z30.4
ICD-10 Finland
Surveillance of contraceptive drugs
1.6
6.2
148
690
H04.10
ICD-10 Finland
Dry eye syndrome
1.2
6.1
1487
9709
OAB95
SPAT
NA
1.3
6.1
567
3377
TLC02
NOMESCO Finland
Simple extraction of IUD
1.3
6.1
472
2746
ED1AA
NOMESCO Finland
Mandipular X-ray examination
0.5
6.1
33
547
N06AX18
ATC
reboxetine; oral
1.5
6.1
174
848
Z12.3
ICD-10 Finland
Special screening examination for neoplasm of breast
0.3
6.1
13
317
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.2
6.0
648
3928
FL1AC
NOMESCO Finland
Left cardioangiography
0.6
6.0
63
853
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
1.3
6.0
489
2863
SPAT1252
SPAT
Overall medication plan or its review
0.8
6.0
688
6214
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7722
36060
1.41
134.69
2.3
2.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
27128
153159
1.33
128.05
3.6
3.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
7043
32943
1.40
119.67
2.2
2.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
32699
192786
1.34
84.63
13.3
14.8
%
40.6
40.0
36.81
25109
144342
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
4973
23313
1.37
79.68
4.4
4.4
%
32.1
32.0
0.23
3482
17325
(46235355) HIV 1 and 2 tests - Meaningful Use set
9843
51347
1.25
70.67
2.1
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
4389
20869
1.34
62.98
2.1
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5945
29591
1.29
61.38
1.8
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
4737
22866
1.33
61.21
6.2
6.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
9434
49621
1.24
61.06
1.7
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1958
8129
1.52
59.39
1.5
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
7259
53944
0.80
59.34
4.8
4.7
ug/l
1.9
2.8
7.41
6447
49073
(40768804) Tissue Pathology biopsy report
15241
84284
1.20
59.16
2.1
2.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
721
8220
0.54
57.95
5.0
5.4
%
0.9
0.9
0.33
675
7692
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
740
8345
0.54
57.29
4.7
5.3
%
1.8
1.7
0.22
689
7807
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
3555
16725
1.35
54.17
2.0
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7350
38215
1.24
51.40
1.5
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
612
7006
0.53
49.79
5.5
5.9
mmol/l
1.3
1.3
0.13
544
6221
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
5640
42409
0.80
49.59
4.0
4.2
%
21.8
21.9
0.07
2374
19345
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1774
15669
0.69
47.70
2.5
2.9
ng/l
133.9
166.4
5.30
1575
14149
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
9893
53431
1.20
46.48
1.3
1.3
u/ml
1.5
1.7
1.25
2419
14750
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
7996
42364
1.22
45.81
1.7
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
8520
45473
1.21
45.16
1.4
1.5
g/l
2.2
2.3
5.25
4999
27913
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1990
16952
0.71
43.20
3.5
4.1
mmol/l
1.2
1.2
0.17
1695
14888
(3048689) Calprotectin [Mass/mass] in Stool
5811
29988
1.24
42.51
2.5
2.5
ug/g
113.9
130.6
3.44
4456
23610
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1354
12301
0.67
42.14
6.7
7.4
mmol/l
24.7
24.6
0.41
1273
11444
(3019225) pH of Specimen
3800
18707
1.29
41.32
4.0
4.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
11390
79037
0.85
41.27
7.1
8.4
inr
1.2
1.2
2.57
3156
24763
(3027273) Bicarbonate [Moles/volume] in Venous blood
917
8984
0.62
40.91
3.3
3.8
mmol/l
25.2
25.2
0.04
888
8684
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5029
25674
1.25
40.36
1.5
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
7226
52011
0.83
39.80
4.0
4.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
1665
7255
1.44
39.49
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
1666
7265
1.44
39.35
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
1666
7269
1.44
39.23
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
1655
7228
1.44
38.77
1.4
1.4
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
411
4911
0.51
38.46
6.7
7.0
mmol/l
104.9
105.2
0.50
372
4436
(3039000) Anion gap in Blood
411
4910
0.51
38.44
6.7
7.0
mmol/l
11.2
11.2
0.04
372
4434
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
3089
14990
1.30
37.27
1.5
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
1757
7823
1.41
36.99
1.5
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1454
12708
0.70
36.51
4.4
5.2
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
17114
97985
1.15
36.07
3.0
3.0
ug/l
94.0
111.8
17.39
15916
91678
(3051387) C reactive protein [Mass/volume] in Capillary blood
412
4732
0.54
33.89
3.6
3.4
mg/l
23.5
24.8
0.32
204
2809
(3003396) Base excess in Arterial blood by calculation
2743
21548
0.77
33.49
7.3
7.7
mmol/l
0.8
1.1
2.83
2196
16942
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
2745
21508
0.78
32.79
7.3
7.8
kpa
5.1
5.1
0.10
2655
20548
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
1709
7734
1.39
32.71
1.9
1.8
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
2745
21495
0.78
32.62
7.2
7.8
kpa
13.2
12.6
5.40
2654
20525
(3023323) Follitropin [Units/volume] in Serum or Plasma
2640
12766
1.30
32.54
1.4
1.4
iu/l
25.4
25.7
0.16
2254
10935
(3050129) First trimester maternal screen panel - Serum or Plasma
2093
9820
1.34
31.89
1.5
1.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
2465
19448
0.77
31.01
7.7
8.1
%
96.1
96.0
0.73
2393
18673
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2634
20514
0.78
29.78
2.9
3.3
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
280
3469
0.50
29.41
2.8
3.4
mmol/l
7.4
7.4
0.02
271
3402
(3008037) Lactate [Moles/volume] in Venous blood
318
3743
0.52
28.43
2.7
3.2
mmol/l
1.5
1.5
0.43
307
3658
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
884
8088
0.67
28.38
3.4
4.2
%
51.6
49.1
2.23
870
8004
(3044889) 12 lead EKG panel
21320
139537
0.88
28.17
3.4
3.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1361
11504
0.72
27.77
3.2
3.9
g/l
131.0
129.4
1.71
1335
11195
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
1270
10847
0.72
27.66
9.6
10.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
2299
18045
0.78
27.61
8.1
8.5
g/l
122.5
121.7
1.07
2229
17357
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
2625
13045
1.27
25.96
1.1
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
835
7573
0.68
25.61
1.9
2.1
ug/l
1.6
2.2
1.34
730
6709
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
24453
144940
1.13
25.41
3.1
3.2
u/l
39.8
45.5
24.53
23008
136888
(3012544) pH of Venous blood
2400
18555
0.79
25.31
4.2
4.7
ph
7.4
7.4
—
6
114
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
6033
42690
0.85
25.13
1.6
1.7
pmol/l
27629633.7
38000321.2
0.62
4973
36058
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
5309
37937
0.85
24.99
3.4
3.6
ng/l
384.7
436.7
0.42
3488
26827
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
27883
166781
1.13
24.28
4.4
4.1
pmol/l
14.6
14.6
5.40
25428
153619
(3020682) Albumin/Creatinine [Ratio] in Urine
8559
58898
0.87
24.03
4.3
4.2
mg/mmol
8.9
9.6
0.59
5169
37725
(36660697) Celiac disease serology panel - Serum
3733
19442
1.21
23.88
1.2
1.2
—
—
—
0
0
(4034850)
678
6306
0.66
23.68
10.7
9.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
2309
17792
0.79
23.59
4.3
4.8
mmol/l
1.7
1.8
0.69
1938
14612
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2935
22011
0.81
23.31
1.7
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
2354
11696
1.26
23.27
1.7
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
1324
6084
1.36
23.08
1.5
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2922
21888
0.81
22.92
1.6
1.8
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
7283
50524
0.87
22.80
2.9
3.0
ng/l
826.5
1160.9
12.37
5856
42773
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
913
3943
1.45
22.76
1.6
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
433
4401
0.61
22.66
3.7
4.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
360
1247
1.80
22.27
1.3
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
8192
56291
0.88
22.12
3.5
3.4
mg/l
305.5
483.7
3.23
5026
36117
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
32066
193925
1.15
21.94
5.2
4.9
mu/l
1.8
2.1
7.94
29724
181156
(3005033) Fetal Nuchal fold Thickness US
1286
5947
1.35
21.54
1.5
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
8729
59657
0.88
21.53
4.1
4.4
ph
7.4
7.4
0.47
1427
12076
(3021447) Carbon dioxide [Partial pressure] in Venous blood
2341
17814
0.80
21.28
4.2
4.8
kpa
5.9
5.8
0.64
2280
17311
(3041806) Other cells [#/volume] in Blood by Manual count
328
1128
1.81
20.81
1.6
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
1280
5956
1.34
20.60
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
1380
6501
1.33
20.44
1.4
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
151
2013
0.46
19.82
2.1
2.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
3558
18792
1.19
19.40
1.4
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
1894
14600
0.79
19.31
3.5
4.1
kpa
4.9
4.7
1.46
1832
14162
(3017143) Hepatitis C virus Ab [Presence] in Serum
5517
30219
1.15
19.13
1.7
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
618
2566
1.50
18.85
2.6
2.0
mg/l
23.7
27.2
0.86
188
748
(3010421) pH of Blood
636
5712
0.69
18.57
3.0
4.0
ph
7.4
7.4
0.71
539
4875
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
3640
19350
1.18
18.39
1.6
1.6
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
914
4119
1.39
18.04
1.5
1.3
u/l
24.9
24.3
0.21
731
3417
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
4589
32423
0.86
18.02
1.8
1.9
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
2549
18877
0.83
17.58
4.2
4.3
%
1.0
0.9
0.52
680
5165
(3004716) Salmonella sp identified in Stool by Organism specific culture
2470
12723
1.22
17.51
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
5232
28739
1.15
17.29
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
2442
12585
1.22
17.22
2.3
2.3
u/l
6383.7
6285.0
0.05
916
4898
(4010399)
2894
15171
1.20
17.08
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
2519
13036
1.21
17.03
1.3
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
31656
191935
1.13
17.00
11.1
12.5
ml/min/173m2
88.4
86.0
67.55
25620
158184
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
1646
8152
1.26
16.71
1.6
1.6
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
551
4979
0.68
16.67
3.1
4.0
kpa
5.0
5.0
0.20
539
4872
(3012501) Base excess in Blood by calculation
551
4978
0.68
16.66
3.1
4.0
mmol/l
2.1
2.4
2.13
358
3304
(3045414) Leukocytes [Presence] in Urine
1960
9916
1.24
16.50
1.9
1.8
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
1358
6579
1.29
16.46
1.4
1.4
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
557
5005
0.69
16.36
3.1
4.0
kpa
8.9
8.8
1.09
545
4897
(40767503) Oxygen content in Capillary blood by calculation
490
4510
0.67
16.34
2.5
2.5
%
17.0
16.7
0.93
256
2307
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
1567
7748
1.27
16.13
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
761
3391
1.40
16.10
1.6
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
4753
33253
0.87
16.08
3.5
3.9
mmol/l
0.8
0.8
3.54
4413
31246
(3021440) Promyelocytes/100 leukocytes in Blood
2430
17926
0.83
16.03
4.3
4.4
%
0.1
0.1
0.09
614
4811
(3013826) Glucose [Moles/volume] in Serum or Plasma
18514
120326
0.91
15.91
4.3
4.9
mmol/l
6.5
6.6
13.89
17036
111486
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
838
3804
1.38
15.88
1.3
1.3
ug/l
3.2
3.6
1.02
777
3438
(3018677) aPTT in Platelet poor plasma by Coagulation assay
4323
30400
0.87
15.71
2.2
2.3
s
29.6
29.7
0.58
4209
29466
(3024561) Albumin [Mass/volume] in Serum or Plasma
13117
86532
0.91
15.45
4.6
5.2
g/l
36.8
36.0
50.07
12127
80749
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2402
17665
0.83
15.30
3.6
4.0
ug/l
17.9
20.3
0.10
1778
13957
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
1556
7747
1.26
15.12
1.8
1.6
mg/l
4.3
3.8
0.55
1074
5442
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
1751
8851
1.24
14.87
1.3
1.3
miu/ml
229.3
225.2
0.18
852
4057
(3026008) Bacteria identified in Urine by Culture
9086
60926
0.90
14.79
2.7
3.0
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
2319
17056
0.83
14.77
4.3
4.4
%
0.1
0.2
0.37
536
4103
(1001926) Buprenorphine [Presence] in Urine by Screen method
1902
9709
1.23
14.73
2.1
2.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
3289
23485
0.86
14.66
6.9
7.5
mmol/l
104.7
104.5
2.72
3244
22952
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
6964
39374
1.12
14.31
1.3
1.3
iu/ml
29.6
32.4
0.62
2003
12152
(21494755) Public health laboratory ask at order entry panel
4189
22959
1.15
14.11
1.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
2003
10342
1.21
13.86
1.6
1.6
mu/l
309.2
310.8
0.06
1815
9276
(3002179) Metamyelocytes/100 leukocytes in Blood
2378
17329
0.84
13.61
4.0
4.1
%
0.7
0.6
0.90
500
3799
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
4287
29885
0.88
13.55
3.0
2.9
ug/l
0.7
0.7
2.11
2673
19494
(3016879) Cocaine [Presence] in Urine
2212
11558
1.20
13.50
2.1
2.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
3087
16595
1.17
13.49
1.2
1.2
iu/ml
134.3
134.3
0.00
1080
6312
(3035320) C reactive protein [Mass/volume] in Body fluid
383
1547
1.54
13.44
2.5
2.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
4217
23220
1.14
13.23
1.4
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
2759
14755
1.17
12.86
2.4
2.4
au/ml
19.0
22.9
1.03
159
765
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
751
6169
0.75
12.73
3.4
3.4
u/ml
1502.1
1917.0
0.11
622
5271
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
8482
48770
1.10
12.41
2.2
2.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
2340
12381
1.18
12.41
2.1
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
12512
82154
0.92
12.38
3.6
3.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
2357
12483
1.18
12.36
2.1
2.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
2350
12447
1.18
12.31
2.1
2.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
2545
13585
1.17
12.14
1.3
1.3
au/ml
42.0
45.6
0.28
79
465
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
6551
37221
1.11
12.08
1.3
1.3
u/ml
10.2
10.8
0.25
2362
14541
(3021901) Oxygen saturation in Capillary blood
407
3657
0.69
12.08
2.8
3.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
739
6036
0.76
12.04
3.8
3.7
u/ml
0.3
0.3
0.13
399
3519
(3021589) Normoblasts [#/volume] in Blood
14640
95413
0.92
11.93
9.0
9.8
e9/l
0.0
0.0
5.73
11711
79741
(3027944) Amphetamines [Presence] in Urine
2307
12235
1.18
11.90
2.0
2.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1229
6126
1.25
11.90
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
11085
73067
0.92
11.88
3.1
3.4
ng/l
45.7
56.0
0.39
6340
45529
(3002385) Erythrocyte distribution width [Ratio]
28081
178321
0.92
11.83
15.1
16.7
%
13.4
13.6
22.31
27519
174966
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
1115
8583
0.80
11.26
2.9
3.4
%
0.6
0.7
3.51
1070
8258
(40761536) Microorganisms panel - Urine sediment
2778
19707
0.86
11.24
3.8
3.9
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
2776
15016
1.16
11.16
1.2
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
353
1462
1.50
11.14
1.4
1.4
nmol/l
30.1
31.9
0.55
323
1336
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
15271
99166
0.93
11.02
6.5
7.2
mmol/l
1.2
1.2
5.20
13099
83804
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
1899
9980
1.19
10.90
1.1
1.1
u/ml
8.2
8.8
0.03
29
154
(3011397) Hemoglobin [Presence] in Urine by Test strip
8426
48685
1.09
10.90
3.5
3.7
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
617
5090
0.75
10.84
2.9
3.2
mmol/l
24.1
24.4
1.19
553
4484
(3003327) Ova and parasites identified in Stool by Light microscopy
1574
8135
1.21
10.84
1.7
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
1086
5397
1.26
10.83
1.3
1.3
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
1149
8773
0.81
10.77
3.0
3.4
%
1.2
1.3
2.74
1142
8726
(3020779) Urea [Moles/volume] in Serum or Plasma
2450
17482
0.86
10.73
7.8
9.2
mmol/l
8.1
9.1
13.25
2322
16780
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
4650
26088
1.12
10.69
1.8
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
635
5203
0.75
10.64
3.7
4.2
kpa
8.9
8.7
1.58
608
4852
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
748
3555
1.31
10.62
1.1
1.1
au/ml
12.8
12.1
0.06
49
201
(3008898) HLA-B27 [Presence]
1671
8703
1.20
10.61
1.1
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
761
3629
1.31
10.54
1.3
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
14613
86486
1.08
10.44
2.4
2.4
nmol/l
76.4
1109.9
0.50
13235
79307
(3047007) Chlamydophila sp Ab [Presence] in Serum
710
3359
1.32
10.42
1.2
1.2
—
—
—
0
0
(3020891) Body temperature
972
7526
0.80
10.37
4.3
5.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
8878
58801
0.92
10.33
3.0
3.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
1561
8101
1.20
10.31
1.4
1.4
u/l
9.9
9.6
0.46
1259
6617
(3010726) Horse dander IgE Ab [Units/volume] in Serum
904
4424
1.27
10.28
1.1
1.1
u/ml
2.3
2.6
0.39
245
1159
(3037522) Nuclear Ab [Titer] in Serum
5502
31220
1.11
10.26
1.4
1.4
titre
563.9
536.3
0.42
1056
6223
(3005322) IgE [Units/volume] in Serum or Plasma
2839
15484
1.15
10.18
1.3
1.3
u/ml
242.7
241.1
0.02
2611
14355
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
1057
5279
1.25
10.12
1.1
1.1
u/ml
2.1
1.6
0.52
466
2227
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
813
3934
1.29
10.11
1.4
1.5
nmol/l
0.5
0.4
2.59
643
3107
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
10320
67875
0.92
10.08
2.6
2.7
u/l
56.7
57.1
0.29
9353
62917
(42870588) Differential panel, method unspecified - Blood
12445
73291
1.08
10.01
6.3
6.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
9680
63814
0.92
10.00
3.4
3.4
mmol/l
7.9
8.0
0.25
8064
54845
(3007461) Platelets [#/volume] in Blood
37729
232676
1.26
9.95
19.1
20.6
e9/l
257.6
254.9
13.07
36782
228059
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
381
3337
0.71
9.88
1.4
1.4
—
—
—
0
0
(1616796) Gas panel - Central venous blood
590
4825
0.76
9.79
2.9
3.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
2587
14062
1.15
9.74
2.8
2.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
37760
232927
1.25
9.51
19.1
20.6
e9/l
6.6
6.7
13.59
36720
227826
(3024731) MCV [Entitic volume]
37750
232864
1.25
9.44
19.0
20.4
fl
90.3
90.5
28.83
37299
230595
(3000963) Hemoglobin [Mass/volume] in Blood
37762
232950
1.25
9.40
19.1
20.6
g/l
136.4
135.9
10.79
37316
230726
(3035941) MCH [Entitic mass]
37748
232857
1.25
9.36
19.0
20.4
pg
30.1
30.2
12.07
37299
230595
(3026361) Erythrocytes [#/volume] in Blood
37751
232884
1.25
9.29
19.0
20.5
e12/l
4.6
4.5
23.18
36674
227797
(3023420) DNA double strand Ab [Units/volume] in Serum
519
2387
1.35
9.28
1.6
1.6
iu/ml
29.1
35.4
0.53
25
120
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
656
5248
0.77
9.25
1.7
1.7
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
368
1600
1.43
9.18
1.6
1.7
mmol/l
6.4
6.7
1.35
316
1156
(3003888) Timothy IgE Ab [Units/volume] in Serum
942
4699
1.25
9.16
1.1
1.1
u/ml
5.8
5.9
0.05
527
2500
(3006462) Nitrate [Presence] in Urine
256
1038
1.53
9.02
3.1
2.9
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
203
787
1.60
8.69
1.1
1.0
u/ml
10.6
10.8
0.02
23
110
(3013115) Eosinophils [#/volume] in Blood
18516
110964
1.07
8.66
6.6
6.6
e9/l
0.2
0.2
1.77
16241
99409
(3020961) Endomysium IgA Ab [Titer] in Serum
2160
11692
1.15
8.63
1.1
1.1
titre
250.5
189.2
0.33
44
316
(3014133) Dog dander IgE Ab [Units/volume] in Serum
760
3725
1.27
8.61
1.1
1.1
u/ml
3.9
4.7
0.69
326
1525
(3023183) Ammonium ion [Moles/volume] in Plasma
549
4447
0.76
8.55
3.3
3.0
umol/l
33.1
34.1
0.55
471
3809
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
237
958
1.54
8.50
1.4
1.4
mu/l
617.4
669.4
0.11
222
913
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
241
978
1.53
8.49
1.4
1.4
%
72.7
73.2
0.22
226
933
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
469
3876
0.75
8.46
1.5
1.5
—
—
—
0
0
(3013512) EKG study
9302
54457
1.08
8.44
3.7
3.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
1632
8667
1.18
8.36
2.9
3.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
3902
26621
0.90
8.33
6.0
7.0
mmol/l
1.0
1.1
2.53
3647
25079
(3014051) Protein [Presence] in Urine by Test strip
997
5061
1.23
8.31
2.1
2.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
693
3378
1.28
8.23
1.1
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
643
5078
0.78
8.22
1.7
1.8
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
591
2824
1.30
8.19
1.4
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
583
2781
1.31
8.18
1.4
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
886
4451
1.24
8.15
1.1
1.1
u/ml
0.7
1.1
2.21
408
1984
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
582
2779
1.30
8.11
1.4
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
581
2777
1.30
8.04
1.4
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
17157
102721
1.07
8.02
6.2
6.3
%
56.1
56.6
7.69
15940
96824
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
607
2928
1.29
7.85
1.1
1.0
u/ml
0.4
0.5
0.04
142
654
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
347
2965
0.72
7.85
1.6
1.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
16536
106305
0.94
7.83
5.5
6.2
umol/l
10.6
10.9
2.52
15479
100688
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
3260
22384
0.89
7.83
4.2
4.4
u/l
230.9
238.5
1.92
3072
21272
(3027456) Digoxin [Moles/volume] in Serum or Plasma
325
2800
0.72
7.75
3.0
3.2
nmol/l
0.8
0.8
1.49
227
2161
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
1204
6274
1.20
7.71
1.3
1.3
u/ml
40.5
33.0
0.48
73
364
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
600
2900
1.29
7.66
1.4
1.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
826
6284
0.81
7.60
1.7
1.8
—
—
—
0
0
(3019977) pH of Arterial blood
106
1152
0.57
7.58
3.7
2.6
ph
7.4
7.4
0.28
32
373
(4211845)
273
1168
1.45
7.52
3.0
2.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
1095
5673
1.20
7.48
1.3
1.3
u/ml
7.6
6.5
0.12
99
607
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
1111
5766
1.20
7.45
1.3
1.3
u/ml
7.7
9.3
0.34
160
895
(3002030) Lymphocytes/100 leukocytes in Blood
17364
104164
1.06
7.38
6.4
6.5
%
29.5
28.8
16.44
16063
97768
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
174
1664
0.65
7.31
1.5
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
677
3344
1.26
7.28
1.1
1.1
u/ml
2.7
2.9
0.17
309
1564
(40761535) Cells panel - Urine sediment
2912
16257
1.12
7.26
3.5
3.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
5472
31533
1.09
7.22
2.9
2.9
e6/l
3.1
3.1
0.00
2715
17327
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
582
2827
1.28
7.18
1.5
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1782
12627
0.87
7.12
6.9
8.1
mmol/l
24.8
24.7
0.23
1770
12518
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
342
1540
1.38
7.11
1.4
1.8
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
725
3624
1.25
7.04
1.9
2.1
titre
7.8
5.2
0.29
17
100
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
280
2424
0.71
6.93
1.7
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
3483
23682
0.90
6.93
22.6
21.9
inr
1.2
1.3
2.71
506
3628
(3029937) Albumin [Presence] in Urine by Test strip
8933
58374
0.93
6.76
4.0
4.0
estimate
0.0
0.0
0.26
2918
21361
(3040151) Glucose [Moles/volume] in Capillary blood
275
2375
0.72
6.73
5.1
7.8
mmol/l
6.8
7.2
1.47
237
1913
(3028707) Methadone [Presence] in Urine by Screen method
1072
5601
1.19
6.72
2.8
3.0
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
340
2840
0.74
6.71
1.4
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
33492
210086
0.92
6.70
13.5
15.6
mmol/l
3.9
4.0
36.45
32519
205287
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
1375
7342
1.17
6.66
1.8
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
302
2565
0.73
6.66
3.0
2.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
307
1374
1.39
6.65
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1504
8091
1.16
6.61
1.5
1.6
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
267
1173
1.42
6.45
1.1
1.1
u/ml
7.2
10.2
0.98
49
198
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
356
1641
1.35
6.44
1.5
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
679
3406
1.24
6.43
1.7
1.7
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
370
1717
1.34
6.41
3.1
3.2
mu/l
28.1
27.7
0.07
344
1617
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
9300
60591
0.94
6.37
2.1
2.2
u/l
190.2
202.1
0.65
8721
57140
(3019198) Lymphocytes [#/volume] in Blood
18343
110501
1.06
6.37
6.3
6.3
e9/l
2.0
1.9
1.05
16164
99097
(3000492) Spirometry study
3767
21466
1.10
6.35
1.4
1.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1360
7288
1.16
6.31
1.7
1.6
iu/ml
0.9
6.4
1.20
233
1460
(3016750) Collection duration of Urine
108
1109
0.60
6.29
2.4
2.3
min
506.2
505.8
0.01
78
819
(3004775) Volume in Urine collected for unspecified duration
147
1405
0.65
6.24
2.2
2.3
ml
736.7
702.0
0.36
98
959
(3017732) Neutrophils [#/volume] in Blood
2784
15638
1.11
6.24
2.6
2.8
e9/l
3.9
4.0
1.80
2113
12647
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
5855
34033
1.08
6.20
2.8
2.8
e6/l
0.9
1.0
4.14
3074
19762
(3027945) Reticulocytes/100 erythrocytes in Blood
3153
21422
0.91
6.18
2.6
2.8
%
1.7
1.7
2.07
2741
19230
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
132
1288
0.63
6.17
1.6
1.5
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
439
2102
1.30
6.12
1.5
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
6060
40022
0.93
6.12
2.7
2.8
mosm/kgh2o
542.1
543.6
0.18
5078
34173
(3019550) Sodium [Moles/volume] in Serum or Plasma
33425
209566
0.92
6.08
13.3
15.5
mmol/l
139.7
139.6
4.42
32529
205084
(3019309) Folate [Moles/volume] in Red Blood Cells
5349
35478
0.93
6.05
1.7
1.8
nmol/l
1132.7
1172.2
2.59
4018
27620
(3023430) Cat dander IgE Ab [Units/volume] in Serum
694
3522
1.23
5.94
1.1
1.1
u/ml
6.4
5.5
0.49
315
1532
(3006184) Hemoglobin [Mass/volume] in Capillary blood
648
4918
0.81
5.92
2.2
2.2
g/l
132.5
131.4
0.57
431
3710
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1469
10402
0.87
5.87
2.7
2.8
e6/l
0.2
0.2
1.11
1427
10116
(4146454)
390
1850
1.31
5.85
2.8
2.8
—
—
—
0
0
(3002256) Pathology report gross observation
4537
26164
1.09
5.84
1.2
1.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
16
324
0.31
5.84
1.9
2.3
u/field
0.7
0.6
0.19
16
324
(3018405) Lactate [Moles/volume] in Arterial blood
886
6516
0.84
5.80
3.8
4.4
mmol/l
1.3
1.4
1.83
874
6396
(3006315) Basophils [#/volume] in Blood
17833
107535
1.05
5.72
6.4
6.3
e9/l
0.0
0.0
0.41
15402
94811
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
372
2996
0.77
5.72
1.5
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
702
3582
1.22
5.72
1.2
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
743
5543
0.83
5.71
1.3
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
595
2984
1.24
5.71
1.7
1.8
titre
3797.3
3602.5
0.04
15
127
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
11186
72276
0.94
5.70
3.1
3.4
u/l
30.4
32.6
2.97
10620
68679
(3019420) Tryptase [Mass/volume] in Serum or Plasma
278
1262
1.37
5.61
1.3
1.6
ug/l
6.0
8.8
3.62
253
1128
(3020191) Ethanol [Moles/volume] in Serum or Plasma
257
2168
0.73
5.51
1.4
1.5
promille
1.5
1.4
0.46
193
1679
(3001604) Monocytes [#/volume] in Blood
17748
107073
1.05
5.51
6.4
6.3
e9/l
0.6
0.6
19.25
15329
94406
(3004616) Nuclear Ab [Presence] in Serum
542
2702
1.25
5.50
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
5196
30207
1.08
5.45
1.7
1.9
%
1.4
1.4
7.64
4602
26776
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
884
6465
0.84
5.44
2.7
2.7
—
—
—
0
0
(3004451) EKG impression Narrative
93
953
0.60
5.44
1.2
1.3
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
352
1665
1.31
5.43
12.4
12.4
mmol/l
0.6
0.6
0.12
329
1529
(3048929) Epstein Barr virus Ab [Presence] in Serum
1633
8967
1.14
5.42
1.3
1.3
—
—
—
0
0
(44790048)
315
2567
0.76
5.33
1.6
1.7
—
—
—
0
0
(44790047)
315
2567
0.76
5.33
1.6
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
1210
6517
1.16
5.32
1.1
1.2
—
—
—
0
0
(44790049)
315
2566
0.76
5.31
1.6
1.7
—
—
—
0
0
(44806118)
315
2565
0.76
5.30
1.6
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
395
3124
0.78
5.29
1.5
1.8
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
896
4716
1.18
5.27
1.3
1.2
u/ml
42.4
43.1
0.03
64
490
(3045788) Cell count panel - Pleural fluid
156
1419
0.68
5.25
1.6
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
1206
6502
1.16
5.24
1.1
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
121
1157
0.65
5.23
1.6
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
7660
49945
0.94
5.23
4.4
4.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
3328
19029
1.09
5.23
2.5
2.6
u/l
38.4
39.9
0.16
2840
16296
(40768443) Skin Pathology biopsy report
1609
8850
1.13
5.21
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1362
7410
1.15
5.21
1.5
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
693
3570
1.21
5.17
1.2
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
685
3525
1.21
5.17
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
482
3712
0.80
5.13
1.8
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
59
669
0.55
5.08
5.2
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
59
669
0.55
5.08
5.2
2.6
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
96
958
0.62
5.05
3.0
3.5
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
1191
6437
1.15
5.02
1.1
1.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
175
1545
0.70
5.01
1.5
1.5
umol/l
57.2
67.6
1.28
13
113
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
124
1167
0.66
4.99
1.6
1.5
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
323
1530
1.31
4.97
1.1
1.1
iu/ml
7.5
7.7
0.06
61
380
(40760888) Immunoglobulin light chains.free panel - Serum
569
4289
0.82
4.94
4.0
3.7
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
133
539
1.53
4.93
5.8
6.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
16133
97281
1.05
4.90
6.5
6.5
%
0.7
0.7
3.52
14921
91353
(40761995) Spermatozoa Progressive [#/volume] in Semen
133
540
1.53
4.89
2.9
3.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
185
1610
0.71
4.88
1.8
1.9
u/field
1.8
2.3
0.79
78
816
(3000850) Epithelial cells [#/volume] in Urine
6696
43753
0.94
4.86
2.5
2.7
e6/l
5.4
6.0
2.87
5764
38286
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
1280
6971
1.14
4.85
1.1
1.1
u/ml
3.2
6.0
3.03
161
859
(3003434) Protein [Mass/volume] in Pleural fluid
243
2024
0.74
4.85
1.5
1.5
g/l
34.3
33.1
0.85
225
1850
(3013650) Neutrophils [#/volume] in Blood by Automated count
20132
122077
1.05
4.80
9.1
9.6
e9/l
3.9
4.0
15.42
17407
108351
(3013707) Erythrocyte sedimentation rate by Westergren method
25715
156861
1.05
4.80
4.2
4.2
mm/h
9.9
11.0
40.77
23863
146954
(3019069) Monocytes/100 leukocytes in Blood
16750
101142
1.05
4.75
6.7
6.8
%
8.4
8.4
2.17
15591
95454
(3044640) Blood type and Crossmatch panel - Blood
10771
64328
1.05
4.75
2.2
2.4
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
879
4667
1.17
4.70
1.2
1.2
u/ml
1.3
6.7
3.82
69
335
(3042631) Mycobacterium sp identified in Specimen
332
2638
0.78
4.68
2.4
2.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
2566
14576
1.10
4.67
3.3
3.3
pmol/l
4.6
4.5
0.60
2257
13083
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
218
984
1.38
4.64
1.9
1.9
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
16656
100600
1.05
4.63
6.4
6.5
%
2.9
2.9
0.16
15417
94419
(3001556) Androgen free Index in Serum or Plasma
78
282
1.72
4.57
1.2
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
262
2136
0.76
4.52
1.5
1.6
%
36.4
32.4
0.91
155
1308
(3023199) Leukocytes [#/volume] in Pleural fluid
218
1824
0.74
4.52
1.6
1.5
e6/l
5458.8
3449.8
0.29
152
1344
(3025941) Bacteria identified in Stool by Culture
2372
13451
1.10
4.48
1.3
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
76
775
0.61
4.44
1.8
2.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
34190
210367
1.07
4.44
12.4
13.9
mg/l
20.1
21.7
17.10
26369
166660
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
608
4505
0.83
4.44
2.4
2.5
ug/min
118.5
125.6
0.11
319
2707
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1731
11912
0.90
4.41
1.5
1.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2842
19095
0.92
4.41
2.5
2.5
g/l
0.2
0.2
6.37
2658
17860
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
51
575
0.55
4.37
8.7
8.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
8446
50211
1.06
4.37
3.8
4.2
%
93.8
92.1
8.79
8232
48880
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
32677
200789
1.06
4.32
4.3
4.2
mmol/l
1.5
1.5
9.72
30421
188432
(3034891) Synovial lining cells/100 cells in Synovial fluid
125
1137
0.68
4.29
1.4
1.5
%
6.0
4.6
0.16
20
246
(3034274) Bile acid [Moles/volume] in Serum --fasting
757
4006
1.18
4.26
2.4
2.2
umol/l
6.3
6.7
0.16
546
2953
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
361
1775
1.26
4.24
1.2
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
26
362
0.45
4.23
5.0
7.8
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
361
1777
1.26
4.21
1.2
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
167
734
1.41
4.20
1.4
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
88
854
0.64
4.18
2.2
2.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
2227
15086
0.91
4.17
2.6
2.7
g/l
67.5
66.6
7.24
2014
13880
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
361
1780
1.26
4.15
1.2
1.2
—
—
—
0
0
(1002224) Polysomnography panel
1656
9267
1.11
4.08
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
99
932
0.66
4.08
3.7
4.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
775
5585
0.86
4.08
4.0
4.6
mmol/l
3.8
3.9
3.81
747
5227
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
490
3671
0.83
4.07
1.8
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
693
3657
1.18
4.06
1.1
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
94
893
0.65
4.05
2.1
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
4542
29879
0.94
4.04
2.0
2.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
37
446
0.51
4.00
1.2
1.3
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
357
1767
1.26
3.99
1.2
1.2
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
71
261
1.69
3.98
1.0
1.1
u/ml
1.3
2.2
0.29
48
204
(40759836) Histone Ab [Presence] in Serum by Immunoblot
356
1763
1.26
3.97
1.2
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
1694
11600
0.90
3.97
8.9
9.9
%
94.2
94.0
0.70
1687
11558
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
2226
15041
0.91
3.95
1.6
1.7
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
356
1765
1.25
3.93
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
257
2055
0.77
3.89
3.1
3.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
691
3660
1.17
3.89
1.1
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
29
374
0.48
3.86
1.7
2.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
31561
193869
1.06
3.84
3.8
3.8
mmol/l
1.3
1.3
19.59
29246
181082
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
981
6919
0.88
3.83
2.2
2.4
ug/l
399.8
449.2
0.24
896
6452
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
852
4595
1.15
3.80
1.2
1.2
u/ml
45.7
9.0
1.32
16
66
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
146
1261
0.72
3.79
1.5
1.3
%
63.6
64.0
0.02
21
144
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
98
397
1.53
3.75
1.2
1.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
489
3622
0.84
3.64
3.0
3.4
u/ml
662.5
580.9
0.06
436
3289
(3036782) Glucose [Moles/volume] in Pleural fluid
182
1509
0.75
3.64
1.3
1.3
mmol/l
6.1
6.2
0.24
174
1400
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
52
550
0.59
3.61
1.7
2.2
e6/l
8815.9
9412.5
0.03
28
306
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
213
1725
0.76
3.59
1.3
1.3
u/ml
—
54.1
—
0
7
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
185
1527
0.75
3.59
1.7
1.8
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
484
2505
1.20
3.58
1.7
1.6
mmol/l
7.5
7.6
0.16
321
1424
(44816559) Phosphatidylethanol [Mass/volume] in Blood
872
4734
1.15
3.57
1.3
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
32884
202304
1.06
3.57
4.3
4.3
mmol/l
4.7
4.7
1.74
30783
190489
(3038071) Oxygen [Partial pressure] in Mixed venous blood
47
509
0.57
3.57
9.3
8.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
15836
100616
0.96
3.54
3.8
4.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
201
1636
0.76
3.53
1.6
1.5
e6/l
25739.8
62542.1
2.93
112
981
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
1489
8357
1.11
3.53
3.6
4.3
mmol/l
24.6
24.7
1.87
1401
7864
(3013005) Retinol [Moles/volume] in Serum or Plasma
213
1005
1.32
3.51
2.0
2.0
umol/l
1.9
2.0
0.85
203
950
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
469
3473
0.84
3.50
1.5
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
687
3672
1.16
3.50
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
2872
16614
1.08
3.48
2.5
2.7
ml/min/173m2
72.0
68.1
4.93
1084
6434
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
41
133
1.91
3.47
1.2
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
140
1198
0.72
3.47
1.2
1.2
u/l
233.3
301.8
0.57
126
1101
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
1249
8617
0.90
3.42
1.9
1.8
g/l
1.4
1.5
2.17
1080
7398
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
63
235
1.66
3.40
1.0
1.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
672
3595
1.16
3.39
1.3
1.2
u/ml
2.7
3.3
0.50
241
1250
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
1109
6139
1.12
3.38
1.4
1.5
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
297
1472
1.25
3.36
1.1
1.1
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
382
2870
0.82
3.35
7.0
6.5
mg/l
11.4
11.2
0.23
357
2642
(3020564) Creatinine [Moles/volume] in Serum or Plasma
35199
219695
0.93
3.33
13.8
15.7
umol/l
72.9
75.0
38.67
35181
219612
(40758558) Short blood count panel - Blood
8812
52781
1.05
3.28
6.8
7.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
9126
54706
1.05
3.28
1.7
1.7
mmol/l
1.4
1.4
3.73
7786
46647
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
225
1081
1.29
3.28
1.8
1.8
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
53
0.00
3.27
0.0
6.7
—
2494.6
—
0
45
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
33
384
0.53
3.26
6.5
7.3
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
62
611
0.63
3.25
1.7
2.3
e6/l
15248.4
2452.7
0.49
42
424
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
646
3460
1.16
3.23
1.3
1.2
u/ml
4.2
3.7
0.62
285
1579
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
543
3939
0.85
3.21
1.5
1.6
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
349
1771
1.22
3.21
1.2
1.2
u/ml
38.5
51.1
0.39
23
65
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
1207
6739
1.11
3.19
1.8
1.7
nmol/l
40.5
40.4
0.02
1159
6598
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
31
94
2.05
3.18
1.1
1.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
1395
9525
0.91
3.16
9.4
10.2
mmol/l
24.3
24.3
0.18
1328
8953
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
176
1433
0.76
3.15
1.3
1.3
u/l
600.5
503.5
0.30
167
1358
(3000330) Specific gravity of Urine by Test strip
1415
9648
0.91
3.12
2.9
3.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
192
1543
0.77
3.12
1.1
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
96
405
1.47
3.11
1.8
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
10489
63137
1.04
3.10
1.6
1.5
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
42
448
0.58
3.07
2.3
2.4
mmol/l
6.8
7.2
0.34
27
263
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
55
204
1.67
3.07
1.1
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1878
10738
1.09
3.07
2.8
3.0
u/ml
32.1
44.3
2.31
1801
10317
(3012441) Differential panel - Pleural fluid
196
1566
0.78
3.05
1.5
1.5
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
102
438
1.45
3.03
1.4
1.3
mu/l
128.4
75.5
0.33
77
332
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
341
1738
1.22
3.03
1.2
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
7366
47436
0.95
3.02
3.9
3.9
kg/l
1.0
1.0
0.44
1216
7030
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
84
348
1.50
2.98
1.1
1.1
u/ml
0.2
0.2
0.07
46
206
(3020717) Zinc [Moles/volume] in Serum or Plasma
248
1223
1.26
2.98
1.6
1.6
umol/l
26.8
21.6
1.75
239
1159
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
1281
7206
1.11
2.97
1.8
1.9
—
—
—
0
0
(3001729) Color of Synovial fluid
10
177
0.35
2.97
1.6
1.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
879
4843
1.13
2.95
1.3
1.4
pmol/l
78.4
116.0
4.66
853
4710
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
55
542
0.63
2.93
1.3
1.4
%
63.4
60.5
0.29
50
453
(4268621)
447
2349
1.18
2.88
2.3
2.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
689
3745
1.14
2.86
1.5
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
550
3945
0.86
2.85
3.0
3.7
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
302
1532
1.22
2.83
1.2
1.3
umol/l
5.6
5.1
1.56
276
1417
(40768806) Pleura Pathology biopsy report
196
1548
0.78
2.81
1.6
1.5
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
39
413
0.59
2.81
1.8
1.7
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
76
313
1.51
2.80
2.4
2.3
ug/l
5.3
3.2
1.16
28
119
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
1562
8900
1.09
2.79
2.0
1.9
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
7081
45563
0.96
2.79
1.5
1.5
nmol/l
21.0
20.3
3.81
6008
39799
(3004809) Band form neutrophils/100 leukocytes in Blood
472
3416
0.86
2.77
3.1
3.3
%
1.5
1.4
0.34
352
2670
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
243
1868
0.81
2.75
2.3
2.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
50
495
0.63
2.74
1.2
1.2
mg/l
113.2
30.6
0.66
39
358
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
105
464
1.41
2.71
1.6
1.6
ug/l
0.4
0.4
0.64
70
312
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
336
1735
1.20
2.66
1.2
1.2
u/ml
49.0
49.1
0.00
24
112
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
64
257
1.55
2.66
2.0
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
391
2861
0.85
2.65
1.2
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
411
2163
1.18
2.64
2.2
2.3
nmol/l
21.1
20.1
1.15
381
2057
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
335
1732
1.20
2.63
1.2
1.2
u/ml
40.6
72.4
1.14
15
80
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
19
244
0.48
2.62
1.3
1.4
%
16.4
11.7
0.29
11
124
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
62
249
1.55
2.58
1.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
459
3308
0.86
2.58
1.5
1.5
mmol/l
64.9
64.0
0.13
376
2604
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
519
2789
1.16
2.57
1.1
1.1
iu/ml
1.8
2.2
—
9
43
(3041918) Cholesterol [Moles/volume] in Pleural fluid
30
332
0.56
2.57
1.2
1.2
mmol/l
2.0
1.8
0.44
19
194
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
129
596
1.34
2.57
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
170
818
1.29
2.55
3.4
2.9
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
268
1361
1.22
2.53
1.2
1.2
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
101
450
1.39
2.52
1.3
1.2
u/ml
7.3
8.8
0.13
26
95
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
636
3474
1.14
2.51
1.1
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
1256
7127
1.10
2.50
1.8
1.8
g/l
1.2
1.2
1.24
1204
6801
(3023520) Reticulocytes [#/volume] in Blood
2401
15862
0.94
2.50
2.5
2.8
e9/l
70.3
69.9
0.16
1729
12167
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
203
1002
1.26
2.49
1.3
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
7801
46875
1.04
2.46
1.8
1.9
mg/l
1.0
1.1
1.69
5621
35107
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
608
4280
0.88
2.45
1.6
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
2448
16145
0.94
2.43
8.3
9.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
172
835
1.28
2.43
1.0
1.0
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
993
5585
1.11
2.39
2.0
1.9
iu/l
4.8
12.5
1.05
352
2071
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
449
2403
1.16
2.38
1.1
1.1
%
94.3
95.9
0.61
425
2250
(3033799) Differential panel - Peritoneal fluid
58
537
0.67
2.37
1.8
2.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
71
631
0.70
2.34
1.2
1.8
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
54
216
1.55
2.32
2.1
2.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
45
437
0.64
2.32
3.8
2.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
2524
16597
0.94
2.30
6.7
7.6
mmol/l
1.3
1.3
3.45
2437
16057
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
10
155
0.40
2.28
3.0
3.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
317
1657
1.19
2.26
1.2
1.2
—
—
—
0
0
(4038314)
48
188
1.58
2.26
1.1
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
130
1046
0.77
2.25
1.5
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
315
1647
1.19
2.24
1.2
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
118
961
0.76
2.24
2.5
2.5
mmol/l
8.5
9.2
1.33
89
694
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
803
5526
0.90
2.23
4.1
3.6
mg/l
30.3
42.8
4.14
672
4406
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
25155
157803
0.97
2.22
7.3
7.7
u/l
74.4
76.8
17.38
23532
149454
(3037467) Urinalysis macro (dipstick) panel - Urine
23884
146438
1.03
2.22
4.3
4.4
—
—
—
0
0
(3017704) Immunofixation for Urine
135
1078
0.78
2.20
1.7
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
147
710
1.29
2.19
3.1
3.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
976
5512
1.10
2.19
1.1
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
65
275
1.47
2.18
1.0
1.1
u/ml
10.6
3.2
0.41
43
212
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
42
407
0.64
2.17
4.5
6.1
%
69.7
68.9
0.06
31
330
(3034860) Kappa light chains.free [Mass/volume] in Serum
806
5535
0.90
2.16
4.1
3.6
mg/l
40.0
56.9
1.10
677
4411
(3035880) pH of Pleural fluid
103
850
0.75
2.16
1.2
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
231
1178
1.22
2.16
1.2
1.2
g/l
1.5
1.5
0.01
11
85
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
730
5038
0.90
2.15
6.6
6.8
iu/ml
1876.1
1557.1
0.08
107
815
(3031040) Bacteria [#/volume] in Urine by Automated count
22680
138976
1.03
2.15
4.4
4.4
e6/l
1274.7
1211.8
0.05
158
2057
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
1216
6946
1.09
2.14
1.8
1.8
g/l
0.2
0.2
2.40
1158
6602
(40768793) Breast Pathology biopsy report
755
4214
1.11
2.14
1.3
1.3
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
40
152
1.63
2.14
1.0
1.1
u/ml
0.4
1.9
2.12
28
109
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
169
834
1.26
2.13
1.3
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
84
375
1.39
2.13
1.1
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
138
665
1.29
2.11
1.3
2.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
148
1159
0.79
2.08
2.2
2.3
umol/l
180.8
143.6
0.52
80
572
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
144
1130
0.79
2.06
1.3
1.3
u/l
17.8
14.9
0.45
136
1034
(3000494) Fungus identified in Specimen by Culture
4388
26154
1.05
2.04
1.5
1.5
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
1556
8999
1.08
2.03
2.1
2.0
u/l
39.9
39.6
0.19
1407
8155
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
590
4100
0.89
2.00
2.8
2.5
nmol/l
0.8
0.9
0.68
473
3445
(4094501)
896
5068
1.10
1.99
1.1
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
605
4192
0.89
1.95
1.2
1.2
titre
301.8
134.2
0.32
11
90
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
181
1375
0.82
1.95
2.9
2.7
%
41.8
39.6
0.54
46
528
(4306422)
627
3486
1.12
1.94
1.2
1.2
—
—
—
0
0
(4035726)
2548
16652
0.95
1.93
1.4
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
13135
79942
1.03
1.92
2.0
1.9
pmol/l
99.7
97.1
7.04
6783
42691
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
45
182
1.53
1.90
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
1351
7795
1.08
1.90
1.8
1.9
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
22
73
1.87
1.87
1.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
222
1148
1.20
1.85
1.3
1.3
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
607
3380
1.12
1.85
1.1
1.1
%
119.2
118.0
0.41
555
3067
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
187
1407
0.82
1.85
1.3
1.5
u/ml
19.8
24.5
0.84
32
268
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
12
31
2.40
1.83
1.8
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
314
1675
1.16
1.83
1.2
1.2
u/ml
15.6
10.8
0.24
25
102
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
303
1613
1.17
1.82
1.4
1.3
pmol/l
60.9
136.9
0.90
123
560
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
48
433
0.69
1.80
1.3
1.3
ug/l
599.1
349.7
0.24
23
233
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
788
5356
0.91
1.78
4.0
3.5
ratio
2.3
3.9
0.61
62
475
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1595
9288
1.07
1.76
1.3
1.3
u/ml
1.3
0.9
0.38
86
808
(3042010) Triglyceride [Moles/volume] in Pleural fluid
26
266
0.61
1.76
1.1
1.3
mmol/l
0.5
1.1
1.37
16
168
(3016018) Differential panel - Cerebral spinal fluid
439
2407
1.13
1.75
1.4
1.5
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
12
153
0.49
1.72
1.3
1.4
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
43
392
0.68
1.72
1.2
1.5
g/l
25.0
39.7
0.47
32
299
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
1003
5748
1.08
1.71
2.3
2.1
mg/l
10.6
10.7
0.28
932
5399
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
103
494
1.29
1.70
1.3
1.2
pmol/l
330.0
324.9
0.04
80
368
(3026692) Albumin [Mass/volume] in Peritoneal fluid
50
442
0.70
1.69
1.2
1.5
g/l
13.6
13.4
0.06
34
337
(3013945) Hepatitis B virus e Ab [Presence] in Serum
13
160
0.50
1.68
1.4
1.6
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
29
109
1.65
1.67
1.1
1.2
u/ml
22.1
16.6
—
5
20
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
163
1228
0.82
1.67
1.5
1.4
u/l
11.9
12.2
0.37
158
1188
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
338
1829
1.15
1.66
1.0
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
894
5107
1.09
1.65
2.5
2.2
g/l
38.9
38.0
4.54
762
4423
(3022475) Manganese [Moles/volume] in Blood
27
100
1.68
1.64
1.1
1.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
173
887
1.21
1.62
1.2
1.2
g/l
0.3
0.3
0.70
144
687
(3044007) Cell count panel - Peritoneal fluid
55
474
0.72
1.62
1.7
2.2
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
36
335
0.67
1.61
2.5
2.9
u/l
1202.9
1810.0
0.29
29
304
(3026250) Tacrolimus [Mass/volume] in Blood
185
1372
0.84
1.61
39.5
38.1
ug/l
7.5
7.4
0.26
175
1257
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
31
120
1.60
1.61
1.1
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
19
205
0.57
1.60
1.4
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
551
3082
1.11
1.59
2.6
2.5
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
21
73
1.79
1.58
1.0
1.1
g/l
0.2
0.2
0.42
15
58
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
156
1172
0.83
1.57
1.0
1.0
ng/l
39.2
43.6
0.59
105
845
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
833
4759
1.09
1.56
2.0
1.9
pmol/l
194.8
191.5
0.37
795
4506
(3039162) Centromere protein B Ab [Units/volume] in Serum
509
2840
1.11
1.55
1.2
1.3
u/ml
54.9
52.6
0.06
30
188
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
156
1170
0.83
1.55
1.0
1.0
ng/l
769.2
761.5
0.08
100
834
(3027231) Wheat IgE Ab [Units/volume] in Serum
113
557
1.26
1.54
1.1
1.1
u/ml
0.6
2.3
—
6
20
(3044009) aPTT.lupus sensitive (LA screen)
50
218
1.42
1.53
1.2
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
104
508
1.27
1.53
1.1
1.1
mg/g
8.0
6.3
0.36
94
481
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
155
1161
0.83
1.52
1.0
1.0
ng/l
307.0
345.6
0.52
106
854
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
864
4950
1.08
1.52
1.4
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
151
1133
0.83
1.51
2.1
2.3
ml
2188.6
1962.4
1.65
135
1023
(3020393) Adenovirus Ag [Presence] in Stool
37
337
0.68
1.51
1.4
1.5
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
13
153
0.53
1.49
1.5
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
48
209
1.43
1.49
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
185
965
1.19
1.48
1.5
1.5
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
255
1366
1.16
1.48
1.4
1.4
mmol/l
5.5
5.5
0.37
232
1285
(3029075) Extractable nuclear Ab panel - Serum
137
694
1.23
1.48
1.0
1.1
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
36
148
1.51
1.47
2.9
3.3
pmol/l
17.1
652.0
0.65
13
45
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
139
706
1.22
1.46
1.1
1.2
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
364
2000
1.13
1.46
4.8
4.4
u/ml
125.8
110.9
0.12
106
615
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
185
966
1.19
1.46
1.5
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
143
1074
0.83
1.46
5.3
5.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
33191
204971
1.03
1.45
4.7
4.7
mmol/l
2.8
2.8
4.09
30878
191881
(3011985) Renin [Units/volume] in Plasma
419
2904
0.89
1.45
1.5
1.6
mu/l
58.6
61.1
0.08
376
2608
(1761868) Lipid panel - Serum or Plasma
11857
74853
0.98
1.44
2.4
2.7
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
203
1070
1.18
1.44
3.7
3.2
mg/l
8.1
8.1
0.03
164
847
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
316
1723
1.14
1.44
1.1
1.1
mg/l
284.5
460.8
0.52
274
1559
(21494814) CD8 cells/100 lymphocytes in Specimen
126
956
0.82
1.43
1.8
2.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
66
306
1.34
1.43
1.3
1.5
nmol/l
540823.3
67849.8
0.82
49
255
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
357
1963
1.13
1.43
1.1
1.2
mg/l
41.3
39.6
0.14
311
1618
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
347
1907
1.13
1.40
1.1
1.1
mg/l
253.4
253.5
0.00
312
1658
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
71
334
1.32
1.40
2.7
2.3
—
—
—
0
0
(44806420)
48
410
0.73
1.38
2.4
2.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
180
944
1.18
1.37
2.1
2.0
mg/l
9.2
9.3
0.07
142
750
(3024471) HLA-A [Type]
137
1024
0.83
1.35
1.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
107
534
1.24
1.35
1.1
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
139
1037
0.83
1.35
3.6
2.2
ug/l
26.5
194.7
1.03
132
987
(3008116) Ketones [Moles/volume] in Urine by Test strip
58
479
0.75
1.35
1.4
1.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
175
1279
0.85
1.34
1.6
1.7
iu/ml
3054103.5
1645556.7
—
10
94
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
15
163
0.57
1.34
1.7
2.3
%
73.5
56.7
—
6
101
(3014178) Parietal cell Ab [Units/volume] in Serum
5
10
3.10
1.33
1.0
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
48
214
1.39
1.33
1.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
2699
16088
1.04
1.33
2.4
2.3
nmol/l
12.2
12.1
0.25
2364
14321
(3004588) Protein electrophoresis panel - Serum or Plasma
1875
12207
0.95
1.32
2.5
2.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
324
1782
1.13
1.32
1.2
1.2
titre
60.0
225.8
2.39
15
57
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
291
1590
1.14
1.31
1.2
1.2
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
282
1986
0.88
1.31
2.2
2.2
%
73.6
72.8
0.40
275
1912
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
45
384
0.73
1.30
3.3
4.2
u/l
32.8
61.2
2.03
17
141
(3036481) Cortisol [Moles/volume] in Serum or Plasma
3471
20807
1.04
1.30
2.1
2.2
nmol/l
365.3
370.9
0.92
3173
19239
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
69
328
1.31
1.29
1.0
1.0
ug/l
76.9
83.2
0.49
56
268
(3025315) Body weight
21
207
0.63
1.28
3.1
5.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
1075
6258
1.07
1.28
1.3
1.3
titre
99.3
116.3
0.33
85
616
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
4289
27426
0.97
1.28
2.5
2.7
%
23.7
23.1
1.68
3771
23211
(3021788) Differential panel - Synovial fluid
673
3851
1.09
1.27
1.6
1.5
—
—
—
0
0
(44813793)
335
1851
1.12
1.27
1.1
1.1
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
279
1961
0.88
1.27
2.1
2.2
%
13.9
13.5
0.23
150
969
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
324
1788
1.13
1.26
1.2
1.2
titre
213.9
187.7
0.19
54
299
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
46
206
1.39
1.26
1.1
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
34
144
1.47
1.25
1.1
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
863
4993
1.07
1.24
1.8
1.7
e6/l
12263.8
13010.5
0.16
615
3698
(3034770) Mitochondria Ab [Titer] in Serum
1056
6153
1.07
1.24
1.3
1.2
titre
1051.3
935.4
0.19
32
164
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
25
99
1.57
1.23
1.5
1.4
—
—
—
0
0
(3009754) Celery IgE Ab [Units/volume] in Serum
10
29
2.14
1.23
1.0
1.0
u/ml
0.0
0.3
—
10
22
(3002079) Sodium [Moles/time] in 24 hour Urine
8
22
2.26
1.23
1.0
1.2
mmol/24h
131.3
133.9
—
8
22
(3020876) Protein [Mass/time] in 24 hour Urine
240
1699
0.88
1.23
2.2
2.1
g/24h
1.2
1.0
0.20
13
87
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
5
11
2.82
1.22
1.0
1.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
103
519
1.23
1.22
1.3
1.3
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
149
779
1.19
1.21
1.7
1.7
au/ml
121.0
135.2
—
9
119
(3005011) Chlamydia sp Ab [Titer] in Serum
68
326
1.29
1.21
1.5
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
932
5413
1.07
1.21
1.3
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
569
3840
0.92
1.20
3.3
3.6
u/ml
1252.2
7149.0
1.05
28
236
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
29601
184708
0.98
1.20
5.3
5.5
mmol/mol
38.3
39.1
41.18
27533
173392
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
272
1906
0.88
1.20
1.6
1.3
nmol/l
1.3
1.5
1.71
241
1730
(3033942) Copper [Moles/time] in 24 hour Urine
26
105
1.54
1.19
1.2
1.3
umol/24h
1.8
1.0
0.21
11
47
(3024932) HLA-DR beta [Type]
137
1009
0.84
1.19
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
127
656
1.20
1.19
1.5
1.7
ug/l
9.6
9.1
0.51
127
656
(3036670) Protein [Mass/volume] in Synovial fluid
113
577
1.22
1.19
1.3
1.3
g/l
40.5
39.9
0.16
54
301
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
35635
220451
1.04
1.18
10.2
10.5
u/l
26.4
26.6
0.87
34487
214256
(3051651) Icteric interference index of Serum or Plasma
162
1176
0.85
1.18
3.3
3.9
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
268
1877
0.89
1.17
2.3
2.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
216
1168
1.15
1.17
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
963
5608
1.07
1.17
2.5
2.5
g/l
0.7
0.8
0.29
825
4853
(40761511) CBC panel - Blood by Automated count
35322
218490
1.04
1.16
11.6
13.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
25
231
0.67
1.16
3.7
2.9
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
164
870
1.17
1.14
1.1
1.1
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
237
1293
1.14
1.13
1.1
1.1
u/l
1.1
1.0
0.69
99
555
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
18
67
1.67
1.13
1.1
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
9730
61396
0.98
1.12
3.2
3.3
e6/l
66.2
68.2
0.04
7163
47502
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
160
849
1.17
1.12
1.1
1.1
ng/l
89.8
904.4
2.29
34
167
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
94
475
1.23
1.11
1.1
1.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
14263
89620
0.98
1.10
5.6
6.5
mmol/l
1.2
1.2
13.60
12839
82025
(3013466) aPTT in Blood by Coagulation assay
20
191
0.65
1.10
1.0
1.1
s
35.0
36.6
1.27
15
160
(3008295) Osmolality of Serum or Plasma
309
2135
0.90
1.09
1.6
1.6
mosm/kgh2o
280.2
280.7
0.13
237
1716
(3049242) von Willebrand panel - Platelet poor plasma
19
73
1.62
1.08
1.5
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
176
1258
0.87
1.07
31.4
28.1
ug/l
119.8
121.2
0.10
141
1039
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
95
483
1.22
1.07
1.7
1.5
nmol/l
0.2
0.2
0.10
72
347
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
98
735
0.83
1.07
1.3
1.2
%
14.2
21.3
0.46
14
128
(3023410) Appearance of Cerebral spinal fluid
393
2218
1.10
1.06
1.5
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
120
883
0.84
1.06
2.7
2.9
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
83
632
0.81
1.05
1.3
1.3
%
45.9
39.2
0.72
50
436
(4212803)
16
159
0.62
1.05
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
311
1735
1.11
1.05
1.2
1.2
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
47
383
0.76
1.05
6.0
5.4
ug/min
32.7
49.2
1.71
32
304
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
776
4507
1.07
1.05
2.7
2.3
g/l
0.0
0.0
0.00
723
4168
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
5
69
0.45
1.04
1.0
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
8380
52919
0.98
1.04
2.4
2.7
umol/l
1714.5
2925.2
4.18
7182
46497
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
946
5533
1.06
1.03
1.5
1.5
iu/ml
9.8
17.0
1.58
21
138
(3026906) Gabapentin [Moles/volume] in Serum or Plasma
5
13
2.39
1.03
1.0
1.1
umol/l
131.4
28.6
—
5
8
(40768795) Lymph node Pathology biopsy report
277
1917
0.90
1.03
1.2
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
785
4568
1.07
1.01
2.7
2.3
g/l
0.0
0.0
0.37
726
4181
(3013166) Neutrophils/100 leukocytes in Synovial fluid
88
662
0.82
1.00
1.4
1.4
%
48.3
53.8
0.67
70
569
(3016273) Islet cell 512 Ab [Units/volume] in Serum
39
178
1.36
1.00
1.0
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
395
2680
0.91
1.00
1.4
1.4
pmol/l
327.6
303.4
0.29
316
2123
(3022948) Iron [Moles/volume] in Serum or Plasma
5094
32346
0.97
0.99
2.4
2.6
umol/l
18.2
13.5
0.62
4732
30038
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
181
981
1.15
0.99
2.9
2.7
au/ml
82.0
159.3
2.30
20
154
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
14
141
0.62
0.99
1.0
1.1
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
40
184
1.35
0.98
1.0
1.1
u/ml
0.3
0.7
1.93
19
107
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
119
869
0.85
0.98
1.0
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
4670
29683
0.97
0.98
2.4
2.6
g/l
2.4
2.4
5.83
4306
27485
(3036603) Volume of Urine
234
1291
1.13
0.98
1.8
1.7
ml
1998.9
1937.0
0.15
40
284
(3042517) Benzodiazepines panel - Urine
80
404
1.23
0.98
1.6
3.3
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
64
496
0.80
0.98
1.1
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
44
206
1.33
0.97
1.2
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
339
2312
0.91
0.96
1.1
1.1
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
844
4935
1.06
0.95
2.6
2.2
g/l
0.0
0.0
0.95
783
4538
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
875
5122
1.06
0.95
1.3
1.4
u/ml
254.6
260.6
0.27
552
3313
(36304419) Bacteria [Presence] in Urine
9016
55065
1.02
0.94
3.1
3.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
2400
15402
0.96
0.94
2.2
2.3
ug/l
6.3
7.4
1.99
2090
13618
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
30
256
0.73
0.94
2.2
3.7
umol/l
56.4
40.7
2.45
25
217
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
505
2903
1.08
0.93
1.3
1.2
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
31
138
1.39
0.93
1.1
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
155
836
1.15
0.93
1.2
1.2
%
110.0
110.3
0.05
143
746
(3026389) Candida sp identified in Specimen by Organism specific culture
602
3999
0.93
0.92
1.3
1.4
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
36
165
1.35
0.92
1.3
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
121
641
1.17
0.91
1.2
1.2
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
7
82
0.53
0.91
1.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
61
302
1.25
0.91
1.2
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
17
160
0.66
0.91
1.4
1.8
umol/l
54.4
47.2
0.32
17
160
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
31943
197432
1.02
0.90
4.4
4.4
mmol/l
5.7
5.8
37.74
29459
183592
(3033923) Metanephrine [Moles/time] in 24 hour Urine
62
477
0.81
0.90
1.0
1.1
umol/24h
0.5
3.8
0.57
27
243
(3022313) Gas panel - Capillary blood
1571
9353
1.04
0.90
3.7
4.2
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
53
258
1.28
0.90
1.0
1.0
u/ml
0.3
0.4
0.25
31
143
(3012989) Citrate [Moles/time] in 24 hour Urine
11
38
1.80
0.90
2.2
1.3
mmol/24h
1.8
2.0
0.23
11
38
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
496
3313
0.93
0.89
1.3
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
28
239
0.73
0.89
1.0
1.1
umol/24h
1.5
3.3
0.62
28
239
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
17
159
0.66
0.88
13.0
9.2
e6/l
205.8
312.4
0.33
12
117
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
27
231
0.73
0.87
1.1
1.1
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
36
167
1.34
0.86
1.0
1.0
u/ml
0.1
2.3
1.58
26
131
(3009015) Lactate [Moles/volume] in Synovial fluid
45
216
1.29
0.86
1.3
1.3
mmol/l
6.4
5.9
0.22
22
99
(3013762) Body weight Measured
8
87
0.57
0.86
1.5
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
65
494
0.82
0.86
1.4
1.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
175
1227
0.88
0.86
1.7
1.6
nmol/l
1.3
1.3
0.20
136
978
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
306
1730
1.10
0.85
2.8
2.6
e6/l
789.9
744.4
0.21
140
686
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
456
3049
0.93
0.85
1.2
1.3
nmol/l
0.2
0.2
0.30
25
168
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
94
491
1.19
0.85
1.7
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
154
837
1.14
0.85
2.5
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
16811
105268
0.98
0.84
3.5
3.6
estimate
0.0
0.0
0.02
2851
21496
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
56
431
0.81
0.84
3.3
2.7
mg/l
61.2
42.4
0.47
11
66
(40763480) Human metapneumovirus Ag [Presence] in Specimen
27
120
1.40
0.84
1.6
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
172
1205
0.89
0.84
1.2
1.3
titre
160.0
439.1
—
5
69
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
95
498
1.18
0.83
1.1
1.1
u/ml
6.5
7.7
0.09
67
353
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
168
1178
0.88
0.83
1.2
1.3
titre
73.3
74.1
0.01
15
108
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
205
1137
1.12
0.83
4.3
6.2
u/ml
47.9
1031.1
1.16
24
238
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
323
2187
0.92
0.83
3.2
3.3
nmol/l
3.3
8.2
1.20
312
2114
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
518
2999
1.07
0.83
1.1
1.1
g/l
1.4
1.5
2.90
457
2740
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
459
2646
1.08
0.82
1.2
1.2
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
0
16
0.00
0.82
0.0
1.0
—
—
—
0
0
(3013931) Oligosaccharides [Presence] in Urine
0
16
0.00
0.82
0.0
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
459
3062
0.93
0.82
1.2
1.3
nmol/l
0.6
1.3
1.05
442
2945
(46235168) Fasting glucose [Moles/volume] in Blood
49
240
1.27
0.81
1.1
2.1
mmol/l
6.3
7.2
0.76
11
66
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
1443
8602
1.04
0.81
2.0
2.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
26
220
0.73
0.80
1.0
1.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
55
274
1.25
0.80
3.4
3.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
17
155
0.68
0.80
7.2
4.9
—
—
—
0
0
(4027681)
273
1542
1.10
0.79
1.2
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
2182
13116
1.03
0.79
1.8
1.9
g/l
1.3
1.3
0.26
1974
12060
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
139
756
1.14
0.78
1.2
1.2
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
237
1622
0.91
0.78
1.9
2.0
mg/l
3.1
3.7
1.83
221
1549
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
110
589
1.16
0.77
1.3
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
15
60
1.55
0.76
7.2
6.5
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
14
55
1.58
0.76
1.4
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
321
2164
0.92
0.76
1.6
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
91
480
1.18
0.76
1.1
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
105
753
0.86
0.75
1.4
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
497
3292
0.94
0.75
1.5
1.4
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
68
350
1.21
0.75
1.5
2.0
ug/l
1.6
2.9
0.98
40
216
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
534
3528
0.94
0.74
1.1
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
58
294
1.22
0.74
1.2
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
42
205
1.27
0.74
1.1
1.2
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
56
283
1.23
0.73
1.0
1.0
u/ml
0.8
0.9
0.06
32
159
(3024980) IgG subclass 4 [Mass/volume] in Serum
646
3788
1.06
0.73
1.6
1.5
g/l
0.7
0.7
0.64
525
2799
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
1498
9638
0.96
0.73
4.7
5.5
mmol/l
24.1
24.1
0.17
1393
8751
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
158
872
1.12
0.72
1.8
2.1
%
147.8
159.4
0.93
149
822
(21494815) CD4 cells/100 lymphocytes in Specimen
314
2111
0.92
0.71
2.2
2.3
%
40.8
40.8
0.01
51
261
(3022493) Free Hemoglobin [Mass/volume] in Plasma
139
974
0.89
0.71
5.7
5.9
mg/l
75.0
2732.4
3.48
106
707
(3024928) Oxygen saturation in Venous blood
633
4153
0.94
0.71
3.3
4.2
—
—
—
0
0
(4024509)
312
2097
0.92
0.71
1.6
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
269
1530
1.09
0.70
1.4
1.4
umol/l
10.8
12.1
3.45
251
1458
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
947
6146
0.95
0.70
4.4
5.2
mg/l
1.4
1.5
4.29
884
5740
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
318
1822
1.08
0.70
13.8
13.3
nmol/l
849.9
1363.5
0.46
304
1766
(3012494) Peanut IgE Ab [Units/volume] in Serum
152
839
1.12
0.70
1.1
1.1
u/ml
3.1
18.7
0.76
88
492
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
56
285
1.22
0.70
1.0
1.0
u/ml
0.5
2.3
0.73
32
152
(3014599) Egg white IgE Ab [Units/volume] in Serum
274
1561
1.09
0.69
1.1
1.1
u/ml
10.3
3.1
0.44
82
449
(4198724)
257
1460
1.09
0.69
2.6
2.4
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
38
185
1.27
0.69
1.1
1.1
u/ml
17.5
30.4
—
7
45
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
38
185
1.27
0.69
1.1
1.1
u/ml
20.7
22.7
—
6
38
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
420
2435
1.07
0.69
1.1
1.1
au/ml
38.2
34.5
—
7
15
(3000034) Microalbumin [Mass/volume] in Urine
269
1816
0.92
0.69
3.2
2.9
mg/l
65.3
50.0
0.26
195
1285
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
199
1362
0.91
0.68
1.3
1.5
u/l
5.6
5.6
0.04
171
1160
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
15
135
0.69
0.68
1.1
1.1
—
610.0
—
0
5
(44806071)
63
326
1.20
0.67
1.0
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
64
332
1.20
0.67
1.6
1.7
pmol/l
36.2
59.9
0.85
51
284
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
183
1256
0.90
0.67
1.3
1.3
u/l
19.5
24.1
1.06
156
1096
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
212
1197
1.10
0.66
1.2
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
21
94
1.39
0.66
1.0
1.1
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
45
226
1.24
0.65
1.2
1.2
mg/l
42.5
47.9
0.42
13
67
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
279
1873
0.92
0.64
3.3
2.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
775
5038
0.95
0.64
1.5
1.5
e6/l
665.6
2452.5
1.60
603
4156
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
273
1834
0.92
0.64
1.4
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
42
321
0.81
0.64
1.4
1.6
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
2052
13093
0.97
0.64
3.5
3.9
kpa
5.1
5.1
1.07
1923
12169
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
33
259
0.79
0.63
1.0
1.3
mmol/l
—
2.3
—
0
10
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
148
1023
0.90
0.63
2.9
3.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
66
346
1.18
0.63
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
139
770
1.12
0.63
1.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
2028
12937
0.97
0.62
3.5
3.9
ph
7.4
7.4
0.71
182
1728
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
191
1302
0.91
0.62
1.6
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
1092
6521
1.04
0.62
2.5
2.5
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
156
871
1.11
0.62
1.1
1.1
%
94.0
91.6
0.41
69
433
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
14
0.00
0.62
0.0
6.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
2797
16957
1.03
0.62
2.6
2.8
g/l
10.4
10.5
0.34
2553
15572
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
775
5032
0.95
0.62
1.4
1.5
e6/l
48.0
28.8
0.49
572
3935
(3030940) RBC casts [#/area] in Urine by Computer assisted method
0
15
0.00
0.60
0.0
1.0
—
—
—
0
0
(3028917) Waxy casts [#/area] in Urine by Computer assisted method
0
15
0.00
0.60
0.0
1.0
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
244
1395
1.09
0.60
1.0
1.0
u/ml
0.5
0.9
0.33
38
230
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
7
72
0.60
0.60
1.0
1.1
mmol/l
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
28
134
1.30
0.59
1.6
1.5
umol/24h
420.8
327.5
0.65
28
134
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
413
2409
1.06
0.59
1.1
1.1
au/ml
28.2
80.0
—
6
25
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
55
286
1.19
0.58
1.9
1.7
mg/l
1.7
1.6
0.10
50
233
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
27
129
1.30
0.58
1.3
1.5
pmol/l
15.6
16.4
0.11
20
104
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
277
1595
1.08
0.58
1.1
1.1
ratio
1.1
1.1
0.84
99
574
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
771
4997
0.96
0.58
1.7
1.7
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
10
39
1.59
0.58
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1652
10554
0.97
0.58
2.3
2.4
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
258
1483
1.08
0.57
1.1
1.2
nmol/l
390.5
375.4
0.60
232
1276
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
418
2751
0.94
0.57
1.2
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
218
1468
0.92
0.56
1.2
1.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
4144
26165
0.98
0.56
1.7
1.8
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
190
1287
0.92
0.56
1.3
1.3
u/l
79.9
93.2
1.27
168
1140
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
98
536
1.13
0.56
1.1
1.4
%
108.1
105.6
0.31
93
507
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
60
436
0.85
0.56
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
227
1300
1.08
0.55
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
62
328
1.17
0.55
1.8
2.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
371
2447
0.94
0.55
2.6
2.5
e9/l
1.2
1.2
0.53
182
1543
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
297
1720
1.07
0.55
2.8
2.7
e9/l
0.2
0.2
0.15
251
1494
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
1.5
1.8
0.13
35
166
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
2.8
2.8
0.01
32
161
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
1.4
1.6
0.17
35
158
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
0.9
0.9
0.02
30
149
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
2.1
0.7
0.82
34
137
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
3.3
3.9
0.30
32
143
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
1.8
2.5
0.60
30
156
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
2.4
1.8
0.23
30
149
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
44
226
1.21
0.54
1.6
1.7
mg/l
1.3
1.5
0.19
30
131
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1064
6375
1.04
0.54
2.6
2.9
%
173.1
181.8
2.73
1017
6019
(3017950) Salicylates [Moles/volume] in Serum or Plasma
6
62
0.60
0.53
1.0
2.3
—
1749.2
—
0
12
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
9
84
0.66
0.53
7.7
8.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
40
204
1.22
0.53
1.7
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
30
148
1.26
0.53
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
8497
52162
1.01
0.52
2.3
2.3
mg/l
2.7
2.8
6.90
7178
45187
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
45
233
1.20
0.52
1.6
1.7
mg/l
1.2
1.6
0.33
35
150
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1832
11082
1.03
0.51
1.6
1.7
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
535
3483
0.95
0.51
1.1
1.1
iu/ml
2109.2
451.8
0.37
127
867
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
67
360
1.16
0.51
1.1
1.1
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
211
1211
1.08
0.51
1.8
2.1
%
134.0
140.2
0.61
204
1134
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
30
149
1.25
0.50
4.0
5.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
429
2806
0.95
0.50
1.6
1.6
%
49.6
55.6
2.35
276
1759
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
7
70
0.62
0.49
1.0
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
70
0.62
0.49
1.0
1.0
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
40
297
0.84
0.49
1.3
1.4
%
48.2
51.5
0.13
20
151
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
7
28
1.55
0.49
1.0
1.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
151
856
1.09
0.49
1.7
1.7
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
30
150
1.24
0.48
2.4
3.1
—
—
—
0
0
(3003577) Lead [Moles/volume] in Blood
22
174
0.78
0.48
1.5
1.4
umol/l
0.3
0.2
—
7
63
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1970
12511
0.98
0.48
3.5
3.9
mmol/l
1.1
1.6
6.92
1461
9132
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
94
520
1.12
0.48
1.1
1.2
%
85.4
90.7
0.45
16
155
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
54
287
1.17
0.48
1.0
1.0
u/ml
0.3
0.2
0.16
32
170
(3025886) Oxalate [Mass/time] in 24 hour Urine
8
74
0.67
0.47
1.8
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
93
515
1.12
0.47
1.1
1.2
%
79.6
79.7
0.00
12
146
(40765096) Chromosome analysis panel by Banding
104
580
1.11
0.46
1.2
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
27
134
1.25
0.46
5.0
6.4
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
7
30
1.45
0.46
2.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
7
30
1.45
0.46
1.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
7
30
1.45
0.46
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
7
30
1.45
0.46
2.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
7
30
1.45
0.46
2.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
7
30
1.45
0.46
1.0
1.0
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
92
638
0.89
0.46
1.4
1.7
iu/ml
—
36667012.6
—
0
9
(3003338) MCHC [Mass/volume]
29170
180460
1.01
0.46
16.0
17.6
g/l
333.1
333.0
2.15
29001
179299
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
71
387
1.14
0.46
1.1
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
19
90
1.31
0.46
2.4
3.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1053
6333
1.03
0.46
2.6
2.3
g/l
2.9
3.0
2.73
819
4871
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
213
1231
1.07
0.45
7.3
6.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
2338
14801
0.98
0.45
4.1
4.4
ng/l
83.4
91.6
4.37
2044
12952
(3004446) Plasmodium sp identified in Blood by Light microscopy
35
260
0.84
0.44
2.7
2.4
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
22
107
1.28
0.44
1.9
1.8
umol/l
0.4
0.7
2.34
14
84
(3022670) pH of Venous cord blood
10
42
1.48
0.44
1.1
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
330
1936
1.06
0.44
1.1
1.1
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
39
203
1.19
0.44
1.0
1.0
u/ml
0.2
1.7
1.33
30
124
(3010503) CD19 cells [#/volume] in Blood
217
1442
0.93
0.44
2.7
2.7
e9/l
0.5
0.3
0.26
212
1410
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
103
707
0.90
0.44
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
860
5518
0.97
0.44
1.5
1.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
433
2818
0.95
0.44
1.5
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
89
615
0.90
0.43
1.2
1.2
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
17
80
1.32
0.43
1.1
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
3811
24000
0.98
0.43
2.7
3.0
umol/l
6.7
7.8
2.60
3239
20627
(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid
0
10
0.00
0.42
0.0
6.7
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
140
798
1.09
0.42
2.5
2.4
e6/l
203.5
435.9
0.68
80
451
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
126
854
0.92
0.42
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
302
1771
1.06
0.42
2.7
2.7
e6/l
526.7
543.9
0.20
253
1492
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
154
882
1.08
0.42
2.7
2.6
ug/l
1.2
1.2
0.17
144
828
(3051593) INR in Capillary blood by Coagulation assay
122
827
0.92
0.41
3.1
9.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
59
321
1.14
0.41
1.3
1.3
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
12
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma
0
12
0.00
0.41
0.0
1.2
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
8
37
1.34
0.40
1.3
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
18
142
0.79
0.40
1.1
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
84
579
0.90
0.40
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
198
1148
1.07
0.40
1.5
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
158
1057
0.93
0.40
1.1
1.1
—
—
—
0
0
(4281824)
291
1907
0.95
0.40
1.1
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
77
533
0.90
0.40
1.6
1.9
u/l
14.8
33.1
2.20
65
476
(3037556) Urate [Mass/volume] in Serum or Plasma
105
593
1.10
0.39
1.2
1.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
280
1643
1.06
0.39
1.1
1.1
u/ml
3.6
2.5
0.28
94
544
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
13
107
0.75
0.39
1.5
1.6
—
—
—
0
0
(3049233) Organic acids panel - Urine
9
40
1.40
0.39
1.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
75
416
1.12
0.39
1.1
1.1
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
36
189
1.18
0.39
1.0
1.0
u/ml
0.4
1.1
0.39
13
67
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
50
355
0.87
0.39
1.3
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
48
259
1.15
0.38
1.2
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
278
1820
0.95
0.38
1.8
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
278
1820
0.95
0.38
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
278
1820
0.95
0.38
1.8
1.8
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
92
518
1.10
0.37
1.2
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
134
899
0.92
0.37
1.5
1.6
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
6
25
1.49
0.37
1.2
1.2
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
5
48
0.65
0.37
1.0
2.9
mu/l
1.4
2.9
—
5
48
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
134
898
0.93
0.37
1.5
1.6
—
—
—
0
0
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
5
50
0.62
0.36
1.2
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
77
0.73
0.36
1.0
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
325
1922
1.05
0.36
19.1
18.8
nmol/l
1440.6
3081.7
0.99
309
1853
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
6
26
1.43
0.36
1.2
1.0
—
—
—
0
0
(3002814) Trichinella spiralis Ab [Titer] in Serum
6
26
1.43
0.36
1.2
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
134
770
1.08
0.36
1.1
1.1
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
12
98
0.76
0.35
1.3
1.4
nmol/l
509.7
494.0
0.03
12
98
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
165
957
1.07
0.35
2.4
2.5
umol/l
47.8
53.9
2.27
137
792
(3015350) Toxocara sp Ab [Presence] in Serum
6
27
1.38
0.35
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
54
377
0.89
0.34
1.1
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
62
429
0.90
0.34
1.5
1.5
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
13
104
0.78
0.33
1.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
12
97
0.77
0.33
1.3
3.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
345
2049
1.05
0.33
1.3
1.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
21
158
0.82
0.33
1.0
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
38
271
0.87
0.33
1.0
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
11737
72390
1.01
0.33
3.8
3.7
e6/l
73.3
79.4
0.30
7810
51190
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
96
547
1.09
0.32
2.5
2.3
ng/l
111.5
111.3
0.01
60
323
(3014891) Appearance of Pleural fluid
23
171
0.83
0.32
1.7
1.7
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
163
1077
0.94
0.32
1.2
1.1
iu/ml
4.3
4.0
0.11
16
76
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
156
907
1.07
0.32
2.2
2.5
nmol/l
144.6
151.8
0.42
137
792
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
62
427
0.90
0.32
1.3
1.2
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
13
103
0.78
0.31
16.2
14.9
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
21
157
0.83
0.31
1.0
1.1
u/l
4.9
7.9
1.41
21
157
(3032743) Legionella sp IgG Ab [Presence] in Serum
19
143
0.82
0.30
1.1
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
445
2861
0.96
0.30
3.7
3.8
u/ml
20.6
39.8
6.45
430
2754
(3028717) Thiamine [Mass/volume] in Blood
35
249
0.87
0.30
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
188
1233
0.95
0.30
1.7
1.7
u/field
2.1
2.2
0.09
97
921
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
29
209
0.86
0.29
1.3
1.4
ml/s/173m2
4.1
1.3
0.50
19
145
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
17
129
0.82
0.29
1.3
1.3
ug/l
65.7
102.2
—
9
77
(3017937) Magnesium [Moles/time] in 24 hour Urine
8
69
0.72
0.29
1.1
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
365
2179
1.04
0.29
1.1
1.1
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
25
182
0.85
0.29
1.0
1.1
u/ml
8.5
9.7
0.09
18
129
(21491868) Cryoglobulin [Mass/volume] in Serum
126
731
1.07
0.29
1.2
1.2
g/l
1.2
0.6
—
6
44
(3032641) Amino acids panel - Urine
8
38
1.31
0.28
1.5
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
972
6168
0.98
0.28
2.8
3.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
33
178
1.15
0.28
1.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
29
208
0.87
0.28
1.4
1.3
nmol/l
21.9
16.5
—
8
55
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
85
486
1.09
0.28
1.2
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
38
267
0.88
0.28
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
103
594
1.08
0.28
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
164
1076
0.95
0.27
1.9
1.8
—
—
—
0
0
(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay
8
40
1.24
0.27
1.3
1.5
%
92.9
52.4
—
8
34
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
8
40
1.24
0.27
1.1
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
184
1083
1.05
0.27
1.1
1.1
u/l
79.2
85.1
0.40
146
860
(3011335) Digoxin [Mass/volume] in Serum or Plasma
16
121
0.82
0.27
2.4
2.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
198
1168
1.05
0.27
1.2
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
85
487
1.08
0.27
1.2
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
181
1183
0.95
0.27
1.4
1.3
nmol/l
140.1
137.8
0.30
181
1183
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
8
41
1.21
0.27
1.0
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
184
1084
1.05
0.27
1.1
1.1
u/l
18.0
23.6
0.69
140
824
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
337
2170
0.96
0.26
1.1
1.1
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
19
98
1.20
0.26
1.1
1.1
u/l
332.4
419.4
0.21
14
85
(3010838) Calcium [Moles/time] in 24 hour Urine
171
1006
1.05
0.26
1.5
1.6
mmol/24h
4.7
5.5
0.47
14
71
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
28
200
0.87
0.26
1.2
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
38
265
0.89
0.26
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
170
1111
0.95
0.26
1.2
1.2
—
—
—
0
0
(3036489) Thrombin time
1329
8103
1.02
0.25
2.2
2.4
s
21.2
21.3
0.48
1137
6918
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
104
603
1.07
0.25
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
83
555
0.93
0.25
5.6
6.2
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
45
251
1.11
0.25
1.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
1417
8939
0.98
0.25
1.6
1.6
u/ml
16.2
14.9
0.10
44
250
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
389
2336
1.03
0.25
1.7
1.8
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
6
51
0.73
0.25
1.0
1.0
u/l
94.8
355.4
—
6
45
(3006598) pH of Arterial cord blood
15
76
1.22
0.24
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
83
478
1.08
0.24
1.1
1.2
—
—
—
0
0
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
24
128
1.16
0.24
1.1
1.1
u/l
50.8
111.8
0.65
19
105
(3015377) Calcium [Moles/volume] in Serum or Plasma
10767
66474
1.01
0.24
3.0
3.3
mmol/l
2.4
2.4
3.83
9211
59018
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
24
172
0.87
0.24
1.2
1.2
—
—
—
0
0
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
20
105
1.18
0.24
1.5
1.6
u/l
0.0
0.1
—
6
35
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
143
936
0.95
0.24
1.9
2.2
ug/min
72.5
92.3
0.20
33
217
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
146
859
1.05
0.23
1.2
1.1
%
94.0
93.5
0.05
63
433
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
23
165
0.86
0.23
1.6
1.5
%
34.2
37.3
0.13
18
114
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
1151
7017
1.02
0.23
2.6
2.7
%
95.0
92.7
2.87
1079
6502
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
48
270
1.10
0.23
2.6
2.6
pmol/l
129.6
57.8
0.70
39
228
(42529582) MDA5 Ab [Presence] in Serum by Line blot
80
533
0.93
0.23
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
80
533
0.93
0.23
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
80
533
0.93
0.23
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
80
533
0.93
0.23
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
68
456
0.93
0.23
2.2
2.4
—
—
—
0
0
(3007700) Barley IgE Ab [Units/volume] in Serum
19
138
0.85
0.22
1.0
1.0
u/ml
1.7
10.6
—
10
70
(3037121) Protein [Mass/volume] in Urine
1145
7227
0.98
0.22
3.4
3.4
g/l
0.4
0.3
0.62
539
3164
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
32
223
0.89
0.22
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
253
1512
1.04
0.22
1.4
1.5
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3015057) Respiratory syncytial virus Ab [Titer] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(40760083) Phosphate/Creatinine [Ratio] in Urine
0
7
0.00
0.22
0.0
4.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
84
487
1.07
0.22
1.2
1.2
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
15
111
0.84
0.22
1.3
1.1
—
—
—
0
0
(3012787) Ethosuximide [Moles/volume] in Serum or Plasma
0
8
0.00
0.21
0.0
4.1
—
302.1
—
0
8
(3020071) Venlafaxine [Mass/volume] in Serum or Plasma
0
8
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum
0
8
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum
0
8
0.00
0.21
0.0
1.0
—
—
—
0
0
(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid
0
8
0.00
0.21
0.0
1.1
—
—
—
0
0
(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum
0
8
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
460
2931
0.97
0.21
1.5
1.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
269
1729
0.97
0.21
4.1
4.0
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
160
1040
0.95
0.21
2.4
2.3
%
29.0
29.2
0.07
155
986
(3010937) Rubella virus Ab [Presence] in Serum
30
165
1.13
0.21
1.1
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
152
899
1.05
0.21
1.1
1.2
%
115.1
107.9
1.59
140
805
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
248
1596
0.96
0.21
2.1
2.4
%
103.7
96.2
2.92
229
1485
(3024139) IgG subclass 3 [Mass/volume] in Serum
411
2480
1.03
0.21
1.4
1.4
g/l
0.4
0.4
0.92
315
1700
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
144
851
1.05
0.21
1.5
1.5
pmol/l
13.6
14.8
2.08
117
713
(3008896) Cortisol [Moles/volume] in Urine
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(3039542) Porphyrins [Moles/time] in 24 hour Urine
0
9
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033463) Neutrophils [#/volume] in Cerebral spinal fluid
0
9
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
411
2481
1.03
0.21
1.4
1.4
g/l
3.1
2.9
1.41
314
1694
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
641
4064
0.98
0.20
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
627
3976
0.98
0.20
1.1
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
379
2286
1.03
0.20
1.1
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
411
2482
1.03
0.20
1.4
1.4
g/l
6.9
6.7
0.37
314
1692
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
42
286
0.91
0.20
2.9
3.4
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
42
237
1.10
0.20
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
641
4062
0.98
0.20
1.2
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
146
865
1.05
0.20
1.2
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
355
2266
0.97
0.19
1.2
1.2
u/l
63.5
67.7
0.27
222
1575
(3000093) Morphology [Interpretation] in Blood Narrative
328
1977
1.03
0.19
1.1
1.2
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
258
1549
1.03
0.19
1.1
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
46
262
1.09
0.19
1.1
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
259
1556
1.03
0.18
1.1
1.1
—
—
—
0
0
(3022725) Serotonin [Moles/volume] in Serum
14
73
1.19
0.18
1.9
1.4
nmol/l
563.4
1018.8
1.13
14
67
(3018738) Hemoglobin F/Hemoglobin.total in Blood
33
185
1.11
0.18
1.8
3.7
%
23.2
10.6
—
7
62
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
21
114
1.14
0.18
1.2
1.9
—
—
—
0
0
(4062490)
409
2476
1.03
0.18
1.5
1.4
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
7
37
1.17
0.18
1.4
1.3
—
—
—
0
0
(4133840)
106
625
1.05
0.18
1.2
1.2
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
40
227
1.09
0.18
3.5
2.6
mg/l
1.4
1.4
0.02
27
156
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
115
748
0.95
0.17
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
386
2337
1.03
0.17
3.5
3.7
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
201
1291
0.97
0.17
1.4
1.4
mmol/l
31.8
33.5
0.47
182
1109
(3035082) Kappa light chains [Mass/volume] in Urine
5
43
0.72
0.17
1.0
1.0
—
0.0
—
0
14
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
47
315
0.93
0.17
1.9
2.5
mmol/l
1.5
1.5
0.01
31
214
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
8
42
1.18
0.17
1.1
1.0
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
346
2093
1.03
0.17
3.1
3.4
%
58.3
57.6
0.21
235
1356
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
146
870
1.04
0.17
2.2
2.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
441
2797
0.98
0.16
3.0
2.9
u/ml
525.4
589.0
0.04
416
2657
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
70
461
0.94
0.16
1.1
1.1
u/ml
63.7
62.6
0.04
70
448
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
22
121
1.13
0.16
1.0
1.0
—
—
—
0
0
(3012403) Metanephrines [Moles/time] in 24 hour Urine
8
44
1.13
0.16
1.3
1.1
—
32.1
—
0
8
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
14
74
1.17
0.16
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
590
3594
1.02
0.16
5.7
5.4
umol/l
377.9
372.7
0.40
527
3153
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
217
1305
1.03
0.16
1.1
1.1
nmol/l
1.7
4.5
1.88
47
229
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
139
897
0.96
0.16
1.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
9
48
1.16
0.15
1.2
1.1
%
1.7
2.8
—
9
48
(3024316) Viscosity of Plasma
16
86
1.15
0.15
2.3
1.8
mpas
1.7
1.5
—
8
58
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
480
2920
1.02
0.15
1.3
1.3
u/l
25.3
38.5
2.04
403
2591
(3033086) Enterovirus NOS Ab [Titer] in Serum
13
94
0.86
0.15
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
21
146
0.89
0.15
1.0
1.1
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
42
281
0.93
0.15
4.3
4.8
mg/l
2.6
2.2
0.48
35
251
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
19
104
1.13
0.15
1.2
1.1
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
7
55
0.79
0.15
1.0
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
98
636
0.96
0.14
1.8
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
69
405
1.06
0.14
1.5
1.4
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
302
1829
1.02
0.14
1.4
1.2
mmol/l
2.0
2.0
0.33
281
1697
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
120
775
0.96
0.14
3.2
2.7
umol/l
27.0
28.2
0.62
89
586
(3007542) Rye IgE Ab [Units/volume] in Serum
26
146
1.11
0.14
1.0
1.0
u/ml
2.3
13.2
0.40
12
68
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
349
2119
1.02
0.14
1.8
1.9
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1078
6768
0.99
0.14
2.7
3.0
g/l
3.5
3.6
0.33
1025
6447
(3034614) HLA Ag [Interpretation]
8
62
0.80
0.14
1.1
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
150
963
0.97
0.14
1.3
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
325
1972
1.02
0.14
1.4
1.4
e6/l
118759.4
98546.8
0.22
234
1313
(3050794) Legionella sp Ab [Presence] in Serum
26
177
0.91
0.13
1.1
1.1
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
17
93
1.13
0.13
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
131
784
1.04
0.13
1.2
1.2
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
9
66
0.85
0.13
1.0
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
924
5664
1.01
0.13
1.4
1.4
mg/l
462.4
524.2
1.90
899
5382
(3012920) Ethanol [Mass/volume] in Serum or Plasma
10
52
1.19
0.13
2.1
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
9026
56190
1.00
0.13
3.2
3.2
e6/l
0.3
0.4
1.24
6503
42707
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
93
553
1.04
0.13
1.2
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
5451
33973
0.99
0.13
2.6
2.9
mmol/l
2.4
2.4
5.35
4683
29760
(3032352) Blasts [#/volume] in Cerebral spinal fluid
42
244
1.07
0.12
2.2
3.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
17
94
1.12
0.12
1.8
2.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
175
1116
0.97
0.12
2.1
2.1
ug/l
2.6
2.3
0.50
140
935
(3041672) Baker's yeast Ab [Presence] in Serum
27
154
1.09
0.12
1.0
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
179
1081
1.03
0.11
1.6
1.6
nmol/l
1.4
8.4
0.83
145
906
(3000570) Elastase.pancreatic [Mass/mass] in Stool
1027
6307
1.01
0.11
1.4
1.4
ug/g
301.8
278.6
1.71
576
3564
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
18
124
0.90
0.11
1.3
1.4
%
0.3
1.7
2.23
13
87
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
16
111
0.89
0.11
1.1
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
88
568
0.96
0.11
1.2
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
174
1108
0.97
0.11
2.3
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
785
4925
0.99
0.10
1.3
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
36
238
0.94
0.10
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
54
352
0.95
0.10
1.6
1.7
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
23
155
0.92
0.10
1.1
1.1
u/l
17.0
21.6
0.77
17
106
(3009677) Dengue virus Ab [Presence] in Serum
19
107
1.10
0.10
1.1
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
74
441
1.04
0.10
1.2
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
119
761
0.97
0.10
1.4
1.2
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
16
110
0.90
0.10
1.1
1.0
u/ml
0.0
0.2
—
6
47
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
21
142
0.92
0.10
2.6
4.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
573
3512
1.01
0.10
1.4
1.4
mmol/l
6.8
6.9
0.77
439
2392
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
201
1220
1.02
0.10
1.1
1.1
u/ml
5.2
14.7
1.08
25
122
(3006245) CD3-CD19+ cells/100 cells in Blood
169
1074
0.98
0.09
2.5
2.5
%
9.5
11.2
1.42
163
997
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
253
1541
1.02
0.09
1.5
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
176
1117
0.98
0.09
2.0
2.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
176
1117
0.98
0.09
2.0
2.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
176
1117
0.98
0.09
2.0
2.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
142
859
1.03
0.09
2.2
2.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
86
552
0.97
0.09
2.2
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
120
765
0.97
0.09
1.9
2.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
16993
105291
1.00
0.08
4.7
4.8
estimate
0.0
0.0
4.43
2974
22079
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
181
1147
0.98
0.08
1.1
1.1
%
97.3
97.2
0.02
144
936
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
18
102
1.10
0.08
1.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
142
860
1.02
0.08
2.2
2.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
11
60
1.14
0.08
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
56
333
1.04
0.08
1.2
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
93
560
1.03
0.08
1.6
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
122
738
1.03
0.08
2.5
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
177
1120
0.98
0.08
2.0
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
131
794
1.02
0.08
1.2
1.2
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
8
46
1.08
0.07
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
996
6225
0.99
0.07
2.6
2.3
g/l
10.2
10.2
0.02
830
5144
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
637
3917
1.01
0.07
1.7
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
110
699
0.98
0.07
1.4
1.6
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
98
593
1.03
0.07
1.4
1.3
nmol/l
99.2
126.7
1.62
70
448
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
289
1770
1.01
0.06
1.8
1.8
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
46
297
0.96
0.06
7.0
6.0
g/mol
109.3
42.3
0.65
40
276
(21494434) Karyotype in Bone marrow
257
1616
0.99
0.06
1.2
1.2
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
33
195
1.05
0.06
1.5
1.5
ug/l
147.3
111.2
0.69
24
157
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
287
1803
0.99
0.06
1.3
1.3
u/ml
0.6
1.2
0.90
125
782
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
99
600
1.02
0.06
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
281
1722
1.01
0.06
1.2
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
55
353
0.97
0.06
2.0
1.9
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
866
5339
1.01
0.06
1.5
1.5
u/ml
27.2
19.6
0.70
20
97
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
215
1315
1.01
0.06
1.5
1.6
u/l
5.1
6.2
0.58
92
650
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
25
164
0.95
0.06
1.1
1.1
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
18
104
1.07
0.05
1.0
1.0
%
34.9
36.1
0.37
18
95
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
18
104
1.07
0.05
1.0
1.0
%
8.8
8.9
0.01
18
94
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
18
104
1.07
0.05
1.0
1.0
%
20.6
21.3
0.23
18
93
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
205
1255
1.01
0.05
1.2
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
134
846
0.98
0.05
1.6
1.8
u/ml
1102.6
30847.3
1.12
21
100
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
49
294
1.03
0.05
1.3
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
52
333
0.97
0.05
1.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
49
314
0.97
0.05
1.7
1.6
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
97
614
0.98
0.05
1.5
1.3
umol/l
16.3
16.9
0.75
88
545
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
205
1287
0.99
0.04
1.4
1.4
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
19
125
0.94
0.04
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
55
332
1.03
0.04
1.1
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
16
106
0.94
0.04
1.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
24
156
0.95
0.04
1.1
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
798
4974
1.00
0.04
1.5
1.6
u/ml
101.2
112.0
1.44
140
1192
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
25
162
0.96
0.03
1.1
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
73
444
1.02
0.03
2.0
2.4
mmol/l
2.5
2.7
0.24
66
401
(4015189)
89
543
1.02
0.03
2.6
2.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
47
284
1.03
0.03
7.9
7.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
17142
106307
1.00
0.03
3.5
3.7
estimate
0.0
0.0
0.46
2901
21392
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
620
3864
1.00
0.03
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
868
5367
1.00
0.03
1.5
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
69
436
0.98
0.03
1.6
1.3
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1073
6676
1.00
0.02
2.6
2.3
g/l
7.3
7.3
0.76
839
4986
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1071
6663
1.00
0.02
2.6
2.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
174
1088
0.99
0.02
1.2
1.2
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
27
173
0.97
0.02
1.0
1.1
u/ml
28.9
20.4
0.36
22
140
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1069
6648
1.00
0.02
2.6
2.3
g/l
3.8
3.8
0.31
806
4757
(3006922) Hepatitis E virus Ab [Presence] in Serum
272
1697
0.99
0.02
1.1
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
37
235
0.98
0.02
1.4
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
198
1236
0.99
0.01
1.1
1.1
miu/ml
1422.1
1514.8
0.57
198
1236
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
810
5015
1.00
0.01
1.3
1.4
mmol/l
3.7
3.7
0.69
769
4720
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
180
1124
0.99
0.01
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
209
1304
0.99
0.01
1.4
1.4
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
11
64
1.07
0.01
1.8
2.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
392
2425
1.00
0.01
1.5
1.4
mmol/l
12.2
11.6
0.51
103
486
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
31
197
0.98
0.01
1.4
1.4
pmol/l
11.1
10.3
0.08
24
160
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
1148
7114
1.00
0.01
1.6
1.6
titre
524.3
246.9
1.50
43
324
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
23
147
0.97
0.01
2.6
4.3
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
41
250
1.02
0.01
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
761
4729
1.00
0.01
1.4
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
124
774
0.99
0.00
1.1
1.1
—
—
—
0
0
(40758358) Immune stain study
14
83
1.05
0.00
1.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
183
1140
1.00
0.00
2.1
2.0
ug/l
3.8
3.8
0.02
161
1012
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
284
1758
1.00
0.00
1.3
1.3
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
53
325
1.01
0.00
1.1
1.0
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
170
1051
1.00
0.00
1.9
2.1
umol/l
13.7
28.2
1.79
15
110
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
18
113
0.99
0.00
1.1
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
20
123
1.01
0.00
1.1
1.2
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
10
63
0.98
0.00
1.2
1.1
nmol/l
164.0
271.1
—
10
63
(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum
12
76
0.98
0.00
1.0
1.0
—
0.3
—
0
18
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
12
76
0.98
0.00
1.1
1.2
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
11
68
1.00
0.00
1.0
1.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
29
180
1.00
0.00
1.3
1.3
—
436.1
—
0
23
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
21
129
1.01
0.00
1.1
1.1
u/field
1.2
1.1
0.42
14
88
(40760410) HLA-B [Type] by High resolution
15
94
0.99
0.00
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
15
94
0.99
0.00
1.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
86
1.01
0.00
3.8
6.8
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
23
143
1.00
0.00
5.2
9.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
97
600
1.00
0.00
1.2
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
15
95
0.98
0.00
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
15
95
0.98
0.00
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
15
96
0.97
0.00
1.0
1.0
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
66
410
1.00
0.00
1.9
1.3
ng/l
131.8
273.2
0.28
41
249
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
21
127
1.03
0.00
1.1
1.0
u/l
2.0
2.3
—
6
21
(3019768) Coxiella burnetii Ab [Presence] in Serum
21
130
1.00
0.00
1.0
1.1
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
5
31
1.00
0.00
1.0
1.0
—
—
—
0
0
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
7
46
0.94
0.00
1.0
1.2
—
—
—
0
0
(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025311) HLA-B [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
5
33
0.94
0.00
1.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
9
55
1.02
0.00
1.1
1.3
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
9
58
0.96
0.00
4.7
5.2
mmol/l
0.2
0.2
—
9
58
(3003195) risperiDONE [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
6
38
0.98
0.00
1.0
1.1
—
—
—
0
0
(3016072) Theophylline [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
6
40
0.93
0.00
1.0
1.1
nmol/24h
131.6
88.5
—
6
40
(3012864) Amino acids [Identifier] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019529) Immunofixation for Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
6
39
0.95
0.00
1.0
1.1
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
7
44
0.99
0.00
1.0
1.1
—
—
—
0
0
(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028050) Streptolysin O Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
6
39
0.95
0.00
1.2
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_CARIES_2_OPER_ONLYAVO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CARIES_2_OPER_ONLYAVO | 0.687 [0.48, 0.97] | 0.036 |
| Birth year | 0.991 [0.98, 1.0] | 0.047 |
During the follow-up period (1.1.1998 — 31.12.2019), 854 out of 168812 females with K11_CARIES_2_OPER_ONLYAVO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_CARIES_2_OPER_ONLYAVO | 0.863 [0.58, 1.29] | 0.474 |
| Birth year | 0.991 [0.98, 1.0] | 0.05 |
During the follow-up period (1.1.1998 — 31.12.2019), 993 out of 130358 males with K11_CARIES_2_OPER_ONLYAVO died.
Mortality risk
Mortality risk for people of age
years, who have K11_CARIES_2_OPER_ONLYAVO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.061% | 0.169% |
| 5 | 0.332% | 0.983% |
| 10 | 0.938% | 2.706% |
| 15 | 1.731% | 5.228% |
| 20 | 2.937% | 8.869% |
Relationships between endpoints
↥Index endpoint: K11_CARIES_2_OPER_ONLYAVO – Dental caries 2 and operation codes, only avohilmo
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data